# EDGAR Filing Document

**Accession Number:** 0001261654
**File Stem:** 0001261654-23-000037
**Filing Date:** 2023-2
**Character Count:** 194565
**Document Hash:** 37ec942a9857d9bdcf692ac3001829e4
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001261654-23-000037.hdr.sgml**: 20230209

**ACCESSION NUMBER**: 0001261654-23-000037

**CONFORMED SUBMISSION TYPE**: 10-Q

**PUBLIC DOCUMENT COUNT**: 94

**CONFORMED PERIOD OF REPORT**: 20221231

**FILED AS OF DATE**: 20230209

**DATE AS OF CHANGE**: 20230209

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** UNIVERSAL TECHNICAL INSTITUTE INC
- **CENTRAL INDEX KEY:** 0001261654
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-EDUCATIONAL SERVICES [8200]
- **IRS NUMBER:** 860226984
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 0930

**FILING VALUES:**
- **FORM TYPE:** 10-Q
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-31923
- **FILM NUMBER:** 23601198

**BUSINESS ADDRESS:**
- **STREET 1:** 4225 EAST WINDROSE DRIVE
- **STREET 2:** SUITE 200
- **CITY:** PHOENIX
- **STATE:** AZ
- **ZIP:** 85032
- **BUSINESS PHONE:** 623-445-9500

**MAIL ADDRESS:**
- **STREET 1:** 4225 EAST WINDROSE DRIVE
- **STREET 2:** SUITE 200
- **CITY:** PHOENIX
- **STATE:** AZ
- **ZIP:** 85032

?xml version="1.0" ? uti-20221231

__________________________________________________________________________________________________________

**UNITED STATES** 

**SECURITIES AND EXCHANGE COMMISSION** 

**WASHINGTON, D.C. 20549**

**FORM 10-Q** 

*(Mark One)*

**☑&nbsp;&nbsp;&nbsp;&nbsp;QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**

**For the quarterly period ended December 31, 2022** 

**☐&nbsp;&nbsp;&nbsp;&nbsp;TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934** 

**For the transition period from _____ to ______**

Commission File Number: 1-31923

**UNIVERSAL TECHNICAL INSTITUTE, INC.**

(Exact name of registrant as specified in its charter)

---

| | |
|:---|:---|
| **Delaware** | **86-0226984** |
| (State or other jurisdiction of<br>incorporation or organization) | (IRS Employer Identification No.) |

---

**4225 East Windrose Drive, Suite 200**

**Phoenix, Arizona 85032**

(Address of principal executive offices, including zip code)

**(623) 445-9500**

(Registrant's telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| **Title of each class** | **Trading Symbol** | **Name of each exchange on which registered** |
| Common Stock, $0.0001 par value | UTI | New York Stock Exchange |

---

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.&nbsp;&nbsp;&nbsp;&nbsp;Yes 🗹&nbsp;&nbsp;&nbsp;&nbsp;No ◻

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).&nbsp;&nbsp;&nbsp;&nbsp;Yes 🗹&nbsp;&nbsp;&nbsp;&nbsp;No ◻

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.

---

| | |
|:---|:---|
| Large accelerated filer ◻ | Accelerated filer 🗹&nbsp;&nbsp;&nbsp;&nbsp;  |
| Non-accelerated filer ◻  | Smaller reporting company ☐ |
| | Emerging growth company ☐ |

---

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ◻

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).&nbsp;&nbsp;&nbsp;&nbsp;Yes ☐&nbsp;&nbsp;&nbsp;&nbsp;No 🗹

At February 1, 2023, there were 33,974,478 shares outstanding of the registrant's common stock.

------

**UNIVERSAL TECHNICAL INSTITUTE, INC.**

**INDEX TO FORM 10-Q FOR THE QUARTER ENDED DECEMBER 31, 2022**

---

| | | |
|:---|:---|:---|
| | | **Page**<br>**Number** |
| <u>[CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS](#i3fd8c9cc921945018616af2cd8eacdac_10)</u> | <u>[CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS](#i3fd8c9cc921945018616af2cd8eacdac_10)</u> | <u>[ii](#i3fd8c9cc921945018616af2cd8eacdac_10)</u> |
| **<u>[PART I.](#i3fd8c9cc921945018616af2cd8eacdac_13)</u>** | **<u>[FINANCIAL INFORMATION](#i3fd8c9cc921945018616af2cd8eacdac_13)</u>** |  |
| <u>[Item 1.](#i3fd8c9cc921945018616af2cd8eacdac_16)</u> | <u>[Financial Statements](#i3fd8c9cc921945018616af2cd8eacdac_16)</u> |  |
|  | <u>[Condensed Consolidated Balance Sheets at](#i3fd8c9cc921945018616af2cd8eacdac_19)[December](#i3fd8c9cc921945018616af2cd8eacdac_19)[3](#i3fd8c9cc921945018616af2cd8eacdac_19)[1](#i3fd8c9cc921945018616af2cd8eacdac_19)[, 202](#i3fd8c9cc921945018616af2cd8eacdac_19)[2](#i3fd8c9cc921945018616af2cd8eacdac_19)[and September 30, 202](#i3fd8c9cc921945018616af2cd8eacdac_19)[2](#i3fd8c9cc921945018616af2cd8eacdac_19)[(Unaudited)](#i3fd8c9cc921945018616af2cd8eacdac_19)</u> | <u>[1](#i3fd8c9cc921945018616af2cd8eacdac_19)</u> |
|  | <u>[Condensed Consolidated Statements of Operations for the Three](#i3fd8c9cc921945018616af2cd8eacdac_22)[Months Ended](#i3fd8c9cc921945018616af2cd8eacdac_22)[December](#i3fd8c9cc921945018616af2cd8eacdac_22)[3](#i3fd8c9cc921945018616af2cd8eacdac_22)[1](#i3fd8c9cc921945018616af2cd8eacdac_22)[, 202](#i3fd8c9cc921945018616af2cd8eacdac_22)[2](#i3fd8c9cc921945018616af2cd8eacdac_22)[and 202](#i3fd8c9cc921945018616af2cd8eacdac_22)[1](#i3fd8c9cc921945018616af2cd8eacdac_22)[(Unaudited)](#i3fd8c9cc921945018616af2cd8eacdac_22)</u> | <u>[2](#i3fd8c9cc921945018616af2cd8eacdac_22)</u> |
|  | <u>[Condensed Consolidated Statements of Other Comprehensive Income for the Three Months Ended December 31, 2022 and 2021 (Unaudited)](#i3fd8c9cc921945018616af2cd8eacdac_25)</u> | <u>[3](#i3fd8c9cc921945018616af2cd8eacdac_25)</u> |
|  | <u>[Condensed Consolidated Statements of Shareholders' Equity as of](#i3fd8c9cc921945018616af2cd8eacdac_28)[December](#i3fd8c9cc921945018616af2cd8eacdac_28)[3](#i3fd8c9cc921945018616af2cd8eacdac_28)[1](#i3fd8c9cc921945018616af2cd8eacdac_28)[, 2022 and 2021 (Unaudited)](#i3fd8c9cc921945018616af2cd8eacdac_28)</u> | <u>[4](#i3fd8c9cc921945018616af2cd8eacdac_28)</u> |
|  | <u>[Condensed Consolidated Statements of Cash Flows for the](#i3fd8c9cc921945018616af2cd8eacdac_31)[Three](#i3fd8c9cc921945018616af2cd8eacdac_31)[Months Ended](#i3fd8c9cc921945018616af2cd8eacdac_31)[December](#i3fd8c9cc921945018616af2cd8eacdac_31)[3](#i3fd8c9cc921945018616af2cd8eacdac_31)[1](#i3fd8c9cc921945018616af2cd8eacdac_31)[, 2022 and 2021 (Unaudited)](#i3fd8c9cc921945018616af2cd8eacdac_31)</u> | <u>[5](#i3fd8c9cc921945018616af2cd8eacdac_31)</u> |
|  | <u>[Notes to Condensed Consolidated Financial Statements (Unaudited)](#i3fd8c9cc921945018616af2cd8eacdac_34)</u> | <u>[7](#i3fd8c9cc921945018616af2cd8eacdac_34)</u> |
| <u>[Item 2.](#i3fd8c9cc921945018616af2cd8eacdac_109)</u> | <u>[Management's Discussion and Analysis of Financial Condition and Results of Operations](#i3fd8c9cc921945018616af2cd8eacdac_109)</u> | <u>[32](#i3fd8c9cc921945018616af2cd8eacdac_109)</u> |
| <u>[Item 3.](#i3fd8c9cc921945018616af2cd8eacdac_145)</u> | <u>[Quantitative and Qualitative Disclosures About Market Risk](#i3fd8c9cc921945018616af2cd8eacdac_145)</u> | <u>[42](#i3fd8c9cc921945018616af2cd8eacdac_145)</u> |
| <u>[Item 4.](#i3fd8c9cc921945018616af2cd8eacdac_148)</u> | <u>[Controls and Procedures](#i3fd8c9cc921945018616af2cd8eacdac_148)</u> | <u>[42](#i3fd8c9cc921945018616af2cd8eacdac_148)</u> |
| **<u>[PART II.](#i3fd8c9cc921945018616af2cd8eacdac_151)</u>** | **<u>[OTHER INFORMATION](#i3fd8c9cc921945018616af2cd8eacdac_151)</u>** |  |
| <u>[Item 1.](#i3fd8c9cc921945018616af2cd8eacdac_154)</u> | <u>[Legal Proceedings](#i3fd8c9cc921945018616af2cd8eacdac_154)</u> | <u>[44](#i3fd8c9cc921945018616af2cd8eacdac_154)</u> |
| <u>[Item 1A.](#i3fd8c9cc921945018616af2cd8eacdac_157)</u> | <u>[Risk Factors](#i3fd8c9cc921945018616af2cd8eacdac_157)</u> | <u>[44](#i3fd8c9cc921945018616af2cd8eacdac_157)</u> |
| <u>[Item 2.](#i3fd8c9cc921945018616af2cd8eacdac_160)</u> | <u>[Unregistered Sales of Equity Securities and Use of Proceeds](#i3fd8c9cc921945018616af2cd8eacdac_160)</u> | <u>[44](#i3fd8c9cc921945018616af2cd8eacdac_160)</u> |
| <u>[Item 3.](#i3fd8c9cc921945018616af2cd8eacdac_163)</u> | <u>[Defaults upon Senior Securities](#i3fd8c9cc921945018616af2cd8eacdac_163)</u> | <u>[44](#i3fd8c9cc921945018616af2cd8eacdac_160)</u> |
| <u>[Item 4.](#i3fd8c9cc921945018616af2cd8eacdac_166)</u> | <u>[Mine Safety Disclosures](#i3fd8c9cc921945018616af2cd8eacdac_166)</u> | <u>[44](#i3fd8c9cc921945018616af2cd8eacdac_160)</u> |
| <u>[Item 5.](#i3fd8c9cc921945018616af2cd8eacdac_169)</u> | <u>[Other Information](#i3fd8c9cc921945018616af2cd8eacdac_169)</u> | <u>[44](#i3fd8c9cc921945018616af2cd8eacdac_160)</u> |
| <u>[Item 6.](#i3fd8c9cc921945018616af2cd8eacdac_172)</u> | <u>[Exhibits](#i3fd8c9cc921945018616af2cd8eacdac_172)</u> | <u>[44](#i3fd8c9cc921945018616af2cd8eacdac_172)</u> |
| **<u>[SIGNATURES](#i3fd8c9cc921945018616af2cd8eacdac_175)</u>** | **<u>[SIGNATURES](#i3fd8c9cc921945018616af2cd8eacdac_175)</u>** | <u>[46](#i3fd8c9cc921945018616af2cd8eacdac_175)</u> |

---

------

<u>[**Table of Contents**](#i3fd8c9cc921945018616af2cd8eacdac_7)</u> 

**CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS**

This Quarterly Report on Form 10-Q and the documents incorporated by reference herein contain forward-looking statements within the meaning of the safe harbor from civil liability provided for such statements by the Private Securities Litigation Reform Act of 1995 (set forth in Section 21E of the Securities Exchange Act of 1934, as amended ("Exchange Act") and Section 27A of the Securities Act of 1933, as amended ("Securities Act"), which include information relating to future events, future financial performance, strategies, expectations, competitive environment, regulation and availability of resources and involve known and unknown risks, uncertainties and other factors which may cause our actual results, performance or achievements to be materially different from any future results, performances or achievements expressed or implied by the forward-looking statements. From time to time, we also provide forward-looking statements in other materials we release to the public as well as verbal forward-looking statements.

In some cases, you can identify forward-looking statements by terms such as "may," "will," "should," "could," "would," "expects," "plans," "anticipates," "believes," "estimates," "projects," "predicts," "potential" and similar expressions (including the negative form of such expressions) intended to identify forward-looking statements, although not all forward looking statements contain these identifying words. Forward-looking statements are based on our current expectations and assumptions, do not strictly relate to historical or current facts, any of which may not prove to be accurate. Many factors could cause actual results to differ materially and adversely from these forward-looking statements. Important factors that could cause actual results to differ from those in our forward-looking statements include, without limitation:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• failure of our schools to comply with the extensive regulatory requirements for school operations;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• our failure to maintain eligibility for federal student financial assistance funds;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• continued Congressional examination of the for-profit education sector;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• our failure to maintain eligibility for or the ability to process federal student financial assistance;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• regulatory investigations of, or actions commenced against, us or other companies in our industry;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• changes in the state regulatory environment or budgetary constraints;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• our failure to execute on our growth and diversification strategy;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• our failure to realize the expected benefits of our acquisitions, including, without limitation, Concorde Career Colleges, Inc.;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• our failure to successfully integrate our acquisitions, including, without limitation, Concorde Career Colleges, Inc.;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• our failure to improve underutilized capacity at certain of our campuses;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• enrollment declines or challenges in our students' ability to find employment as a result of macroeconomic conditions;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• our failure to maintain and expand existing industry relationships and develop new industry relationships;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• our ability to update and expand the content of existing programs and develop and integrate new programs in a timely and cost-effective manner while maintaining positive student outcomes;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• our failure to effectively identify, establish and operate additional schools, programs or campuses;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the effect of our principal stockholder owning a significant percentage of our capital stock, and thus being able to influence certain corporate matters and the potential in the future to gain substantial control over our company;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the impact of certain holders of our Series A Preferred Stock owning a significant percentage of our capital stock, their ability to influence and control certain corporate matters and the potential for future dilution to holders of our common stock;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• a loss of our senior management or other key employees;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the effect of public health pandemics, epidemics or outbreak, including COVID-19; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• risks related to other factors discussed in our <u>[202](http://www.sec.gov/ix?doc=/Archives/edgar/data/1261654/000126165422000105/uti-20220930.htm)[2](http://www.sec.gov/ix?doc=/Archives/edgar/data/1261654/000126165422000105/uti-20220930.htm)[Annual Report on Form 10-K](http://www.sec.gov/ix?doc=/Archives/edgar/data/1261654/000126165422000105/uti-20220930.htm)</u> filed with the SEC on December 12, 2022 (the "2022 Annual Report on Form 10-K").

The factors above are not exhaustive, and new factors may emerge or changes to the foregoing factors may occur that could impact our business. We cannot guarantee that any forward-looking statement will be realized. Achievement of future results is subject to risks, uncertainties and potentially inaccurate assumptions. Many events beyond our control may determine whether results we anticipate will be achieved. Should known or unknown risks or uncertainties materialize, or should underlying assumptions prove inaccurate, actual results could differ materially from past results and those anticipated,

ii

------

<u>[**Table of Contents**](#i3fd8c9cc921945018616af2cd8eacdac_7)</u> 

estimated or projected. Among the factors that could cause actual results to differ materially are the factors discussed under Item 7. "Management's Discussion and Analysis of Financial Condition and Results of Operations." You should bear this in mind as you consider forward-looking statements.

Also, these forward-looking statements represent our estimates and assumptions only as of the date of the document containing the applicable statement. Except as required by law, we undertake no obligation to update or revise forward looking statements, whether as a result of new information, future events or otherwise. Thus, you should not assume that our silence over time means that actual events are bearing out as expressed or implied in such forward-looking statements. We qualify all of the forward-looking statements in this Quarterly Report on Form 10-Q, including the documents that we incorporate by reference herein, by these cautionary statements. You are advised, however, to consult any further disclosures we make on related subjects in our reports and filings with the Securities and Exchange Commission ("SEC").

iii

------

<u>[**Table of Contents**](#i3fd8c9cc921945018616af2cd8eacdac_7)</u> 

**PART I. FINANCIAL INFORMATION**

**Item 1. FINANCIAL STATEMENTS**

**UNIVERSAL TECHNICAL INSTITUTE, INC. AND SUBSIDIARIES**

**CONDENSED CONSOLIDATED BALANCE SHEETS**

(In thousands, except par value and per share amounts)

(Unaudited)

---

| | | |
|:---|:---|:---|
| | **December 31,<br>2022** | **September 30,<br>2022** |
| **Assets** | | |
| Cash and cash equivalents | $162229 | $66452 |
| Restricted cash | 4542 | 3544 |
| Held-to-maturity investments |  | 28918 |
| Receivables, net | 22252 | 16450 |
| Notes receivable, current portion | 5727 | 5641 |
| Prepaid expenses | 11422 | 6139 |
| Other current assets | 8871 | 8809 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total current assets | 215043 | 135953 |
| Property and equipment, net | 240836 | 214292 |
| Goodwill | 26992 | 16859 |
| Intangible assets, net | 18895 | 14215 |
| Notes receivable, less current portion | 30767 | 30231 |
| Right-of-use assets for operating leases | 199947 | 132038 |
| Deferred tax asset, net | 6097 | 3365 |
| Other assets | 9496 | 5958 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total assets | $748073 | $552911 |
| **Liabilities and Shareholders' Equity** |  |  |
| Accounts payable and accrued expenses | $62855 | $66680 |
| Dividends payable | 1277 |  |
| Deferred revenue | 75328 | 54223 |
| Operating lease liability, current portion | 24206 | 12959 |
| Long-term debt, current portion | 1945 | 1115 |
| Other current liabilities | 3601 | 2745 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total current liabilities | 169212 | 137722 |
| Operating lease liability | 195730 | 129302 |
| Long-term debt | 161029 | 66423 |
| Other liabilities | 4816 | 4067 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total liabilities | 530787 | 337514 |
| Commitments and contingencies (Note 16) |  |  |
| Shareholders' equity: |  |  |
| &nbsp;&nbsp;Common stock, $0.0001 par value, 100,000 shares authorized, 34,007 and 33,857 shares issued | 3 | 3 |
| &nbsp;&nbsp;Preferred stock, $0.0001 par value, 10,000 shares authorized; 676 shares of Series A Convertible Preferred Stock issued and outstanding, liquidation preference of $100 per share |  |  |
| &nbsp;&nbsp;Paid-in capital - common | 149016 | 148372 |
| &nbsp;&nbsp;Paid-in capital - preferred | 66481 | 66481 |
| &nbsp;&nbsp;Treasury stock, at cost, 82 shares  | (365) | (365) |
| &nbsp;&nbsp;Retained earnings (deficit) | 64 | (1307) |
| &nbsp;&nbsp;Accumulated other comprehensive income | 2087 | 2213 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total shareholders' equity | 217286 | 215397 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total liabilities and shareholders' equity | $748073 | $552911 |

---

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

------

<u>[**Table of Contents**](#i3fd8c9cc921945018616af2cd8eacdac_7)</u> 

**UNIVERSAL TECHNICAL INSTITUTE, INC. AND SUBSIDIARIES**

**CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS** 

(In thousands, except per share amounts)

(Unaudited)

---

| | | |
|:---|:---|:---|
| | **Three Months Ended** | **Three Months Ended** |
| | **December 31,** | **December 31,** |
| | **2022** | **2021** |
| **Revenues** | $120004 | $105075 |
| **Operating expenses:** |  |  |
| &nbsp;&nbsp;&nbsp;Educational services and facilities | 61408 | 47901 |
| &nbsp;&nbsp;&nbsp;Selling, general and administrative | 54148 | 43596 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Total operating expenses** | 115556 | 91497 |
| **Income from operations** | 4448 | 13578 |
| **Other income (expense):** |  |  |
| &nbsp;&nbsp;&nbsp;Interest income | 823 | 12 |
| &nbsp;&nbsp;&nbsp;Interest expense | (1423) | (233) |
| &nbsp;&nbsp;&nbsp;Other income, net | 325 | 118 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Total other expense, net** | (275) | (103) |
| **Income before income taxes** | 4173 | 13475 |
| Income tax (expense) benefit (See Note 15) | (1525) | 1347 |
| **Net income** | 2648 | 14822 |
| Preferred stock dividends | (1277) | (1323) |
| Income available for distribution | 1371 | 13499 |
| Income allocated to participating securities | (514) | (5267) |
| **Net income available to common shareholders** | $857 | $8232 |
| **Earnings per share (See Note 18):**  |  |  |
| &nbsp;&nbsp;Net income per share - basic | $0.03 | $0.25 |
| &nbsp;&nbsp;Net income per share - diluted | 0.02 | 0.25 |
| **Weighted average number of shares outstanding:** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Basic | 33805 | 32849 |
| &nbsp;&nbsp;&nbsp;&nbsp;Diluted | 34408 | 33572 |

---

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

------

<u>[**Table of Contents**](#i3fd8c9cc921945018616af2cd8eacdac_7)</u> 

**UNIVERSAL TECHNICAL INSTITUTE, INC. AND SUBSIDIARIES**

**CONDENSED CONSOLIDATED STATEMENTS OF OTHER COMPREHENSIVE INCOME**

(In thousands)

(Unaudited)

---

| | | |
|:---|:---|:---|
| | **Three Months Ended** | **Three Months Ended** |
| | **December 31,** | **December 31,** |
| | **2022** | **2021** |
| Net income | $2648 | $14822 |
| Other comprehensive income: |  |  |
| &nbsp;&nbsp;&nbsp;Unrealized (loss) gain on interest rate swap, net of taxes | (126) | 173 |
| Comprehensive income | $2522 | $14995 |

---

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

------

<u>[**Table of Contents**](#i3fd8c9cc921945018616af2cd8eacdac_7)</u> 

**UNIVERSAL TECHNICAL INSTITUTE, INC. AND SUBSIDIARIES**

**CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY** 

(In thousands)

(Unaudited)

---

| | | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Common Stock** | **Common Stock** | **Preferred Stock** | **Preferred Stock** | **Paid-in<br>Capital - Common** | **Paid-in<br>Capital - Preferred** | **Treasury Stock** | **Treasury Stock** | **Retained Earnings (Deficit)** | **Accumulated Other Comprehensive Income** | **Total<br>Shareholders'<br>Equity** |
| | **Shares** | **Amount** | **Shares** | **Amount** | **Paid-in<br>Capital - Common** | **Paid-in<br>Capital - Preferred** | **Shares** | **Amount** | **Retained Earnings (Deficit)** | **Accumulated Other Comprehensive Income** | **Total<br>Shareholders'<br>Equity** |
| **Balance as of September 30, 2022** | 33857 | $3 | 676 | $— | $148372 | $66481 | (82) | $(365) | $(1307) | $2213 | $215397 |
| Net income |  |  |  |  |  |  |  |  | 2648 |  | 2648 |
| Issuance of common stock under employee plans | 223 |  |  |  |  |  |  |  |  |  |  |
| Shares withheld for payroll taxes | (73) |  |  |  | (525) |  |  |  |  |  | (525) |
| Stock-based compensation |  |  |  |  | 1169 |  |  |  |  |  | 1169 |
| Preferred stock dividends |  |  |  |  |  |  |  |  | (1277) |  | (1277) |
| Unrealized loss on interest rate swap, net of taxes |  |  |  |  |  |  |  |  |  | (126) | (126) |
| **Balance as of December 31, 2022** | 34007 | $3 | 676 | $— | $149016 | $66481 | (82) | $(365) | $64 | $2087 | $217286 |

---

---

| | | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Common Stock** | **Common Stock** | **Preferred Stock** | **Preferred Stock** | **Paid-in<br>Capital - Common** | **Paid-in<br>Capital - Preferred** | **Treasury Stock** | **Treasury Stock** | **Retained Deficit** | **Accumulated Other Comprehensive Income (Loss)** | **Total<br>Shareholders'<br>Equity** |
| | **Shares** | **Amount** | **Shares** | **Amount** | **Paid-in<br>Capital - Common** | **Paid-in<br>Capital - Preferred** | **Shares** | **Amount** | **Retained Deficit** | **Accumulated Other Comprehensive Income (Loss)** | **Total<br>Shareholders'<br>Equity** |
| **Balance as of September 30, 2021** | 32915 | $3 | 700 | $— | $142314 | $68853 | (82) | $(365) | $(21996) | $(279) | $188530 |
| Net income |  |  |  |  |  |  |  |  | 14822 |  | 14822 |
| Issuance of common stock under employee plans | 111 |  |  |  |  |  |  |  |  |  |  |
| Shares withheld for payroll taxes | (37) |  |  |  | (301) |  |  |  |  |  | (301) |
| Stock-based compensation |  |  |  |  | 706 |  |  |  |  |  | 706 |
| Preferred stock dividends |  |  |  |  |  |  |  |  | (1323) |  | (1323) |
| Unrealized gain on interest rate swap |  |  |  |  |  |  |  |  |  | 173 | 173 |
| **Balance as of December 31, 2021** | 32989 | $3 | 700 | $— | $142719 | $68853 | (82) | $(365) | $(8497) | $(106) | $202607 |

---

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

------

**UNIVERSAL TECHNICAL INSTITUTE, INC. AND SUBSIDIARIES**

**CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS** 

(In thousands)

(Unaudited)

---

| | | |
|:---|:---|:---|
| | **Three Months Ended December 31,** | **Three Months Ended December 31,** |
| | **2022** | **2021** |
| **Cash flows from operating activities:** |  |  |
| Net income | $2648 | $14822 |
| Adjustments to reconcile net income to net cash provided by operating activities: |  |  |
| &nbsp;&nbsp;&nbsp;Depreciation and amortization | 5248 | 3679 |
| &nbsp;&nbsp;&nbsp;Amortization of right-of-use assets for operating leases | 4120 | 4472 |
| &nbsp;&nbsp;&nbsp;Bad debt expense | 535 | 560 |
| &nbsp;&nbsp;&nbsp;Stock-based compensation | 1169 | 706 |
| &nbsp;&nbsp;&nbsp;Deferred income taxes | 1068 | (1893) |
| &nbsp;&nbsp;&nbsp;Training equipment credits earned, net | (83) | (147) |
| &nbsp;&nbsp;&nbsp;Unrealized (loss) gain on interest rate swap | (126) | 173 |
| &nbsp;&nbsp;&nbsp;Other (gains) losses, net | (143) | (148) |
| Changes in assets and liabilities: |  |  |
| &nbsp;&nbsp;&nbsp;Receivables | 4657 | 4920 |
| &nbsp;&nbsp;&nbsp;Prepaid expenses | (1438) | (590) |
| &nbsp;&nbsp;&nbsp;Other assets | 2079 | (29) |
| &nbsp;&nbsp;&nbsp;Notes receivable | (622) | (1514) |
| &nbsp;&nbsp;&nbsp;Accounts payable and accrued expenses | (15925) | (8367) |
| &nbsp;&nbsp;&nbsp;Deferred revenue | 4634 | (8666) |
| &nbsp;&nbsp;&nbsp;Operating lease liability | (4963) | (2567) |
| &nbsp;&nbsp;&nbsp;Other liabilities | (46) | (2955) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net cash provided by operating activities | 2812 | 2456 |
| **Cash flows from investing activities:** |  |  |
| &nbsp;&nbsp;&nbsp;Cash paid for acquisition, net of cash acquired | (16973) | (26142) |
| &nbsp;&nbsp;&nbsp;Purchase of property and equipment | (6782) | (10792) |
| &nbsp;&nbsp;&nbsp;Proceeds from maturities of held-to-maturity securities | 29000 |  |
| &nbsp;&nbsp;&nbsp;Return of capital contribution from unconsolidated affiliate |  | 75 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net cash provided by (used in) investing activities | 5245 | (36859) |
| **Cash flows from financing activities:** |  |  |
| &nbsp;&nbsp;&nbsp;Proceeds from revolving credit facility | 90000 |  |
| &nbsp;&nbsp;&nbsp;Debt issuance costs related to the revolving credit facility | (484) |  |
| &nbsp;&nbsp;&nbsp;Payments on term loans and finance leases | (273) | (216) |
| &nbsp;&nbsp;&nbsp;Payment of payroll taxes on stock-based compensation through shares withheld | (525) | (301) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net cash provided by (used in) financing activities | 88718 | (517) |
| Change in cash, cash equivalents and restricted cash | 96775 | (34920) |
| Cash and cash equivalents, beginning of period | 66452 | 133721 |
| Restricted cash, beginning of period | 3544 | 12256 |
| Cash, cash equivalents and restricted cash, beginning of period | 69996 | 145977 |
| Cash and cash equivalents, end of period | 162229 | 99513 |
| Restricted cash, end of period | 4542 | 11544 |
| Cash, cash equivalents and restricted cash, end of period | $166771 | $111057 |

---

------

**UNIVERSAL TECHNICAL INSTITUTE, INC. AND SUBSIDIARIES**

**CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (CONTINUED)**

(In thousands)

(Unaudited)

---

| | | |
|:---|:---|:---|
| | **Three Months Ended December 31,** | **Three Months Ended December 31,** |
| | **2022** | **2021** |
| **Supplemental disclosure of cash flow information:** |  |  |
| Interest paid | $1465 | $223 |
| Training equipment obtained in exchange for services | 174 | 221 |
| Depreciation of training equipment obtained in exchange for services | 198 | 238 |
| Accounts payable and accrued expenses for capital expenditures | 2837 | 3651 |
| Preferred dividends payable | 1277 | 1323 |
| CARES Act funds received for student emergency grants |  | 2816 |
| CARES Act funds disbursed for student emergency grants |  | (2900) |

---

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

------

<u>[**Table of Contents**](#i3fd8c9cc921945018616af2cd8eacdac_7)</u>

**UNIVERSAL TECHNICAL INSTITUTE, INC. AND SUBSIDIARIES**

**NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS**

(In thousands, except per share amounts)

(Unaudited)

**Note 1** - **Nature of the Business**

Universal Technical Institute, Inc., which together with its subsidiaries is referred to as the "Company", "we," "us" or "our," was founded in 1965 and is a leading workforce solutions provider of transportation, skilled trades and healthcare education programs, whose mission is to serve students, partners, and communities by providing quality education and support services for in-demand careers across a number of highly-skilled fields. We offer the majority of our programs in a blended learning model that combines instructor-facilitated online teaching and demonstrations with hands-on labs. As a result of the Concorde Career Colleges, Inc. acquisition on December 1, 2022 (the "Concorde Acquisition"), beginning with this reporting period we have two reportable segments as follows:

***Universal Technical Institute ("UTI"):*** UTI operates 16 campuses located in nine states and offers a wide range of degree and non-degree transportation and skilled trades technical training programs under brands such as Universal Technical Institute, Motorcycle Mechanics Institute, Marine Mechanics Institute, NASCAR Technical Institute, and MIAT College of Technology ("MIAT"). UTI also offers manufacturer specific advanced training programs, which include student-paid electives, at our campuses and manufacturer or dealer sponsored training at certain campuses and dedicated training centers. Lastly, UTI provides dealer technician training or instructor staffing services to manufacturers. UTI works closely with over 35 original equipment manufacturers and industry brand partners to understand their needs for qualified service professionals.

***Concorde Career Colleges ("Concorde"):*** Concorde operates across 17 campuses in eight states, offering degree, non-degree, and continuing education programs in the allied health, dental, nursing, patient care and diagnostic fields. Concorde believes in preparing students for their health care careers with practical, hands-on experiences including opportunities to learn while providing care to real patients. Prior to graduation, students will complete a number of hours in a clinical setting or externship, depending upon their program of study. We acquired Concorde on December 1, 2022. See Note 4 on "Acquisitions" for additional information.

"Corporate" includes corporate related expenses that are not allocated to the UTI or Concorde reportable segments. These costs were previously allocated across our former "Postsecondary Education" reportable segment and "Other" category based upon compensation expense. Additional information about our reportable segments is presented in Note 19.

Our primary source of revenues is currently tuition and fees paid by students. To pay for a substantial portion of their tuition, the majority of students rely on funds received from federal financial aid programs under Title IV of the Higher Education Act of 1965, as amended ("HEA"), as well as other federal programs. For further discussion, see Note 2 on "Summary of Significant Accounting Policies - Concentration of Risk" and Note 24 on "Government Regulation and Financial Aid" included in our <u>[2022 Annual Report on Form 10-K](http://www.sec.gov/ix?doc=/Archives/edgar/data/1261654/000126165422000105/uti-20220930.htm)</u> filed with the SEC on December 12, 2022 (the "2022 Annual Report on Form 10-K").

**Note 2 - Basis of Presentation**

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America ("GAAP") for interim financial information and the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, our condensed consolidated financial statements do not include all the information and footnotes required by GAAP for complete financial statements. Normal and recurring adjustments considered necessary for a fair statement of the results for the interim periods have been included. Operating results for the three months ended December 31, 2022 are not necessarily indicative of the results that may be expected for the year ending September 30, 2023. The accompanying condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes thereto included in our <u>[2022 Annual Report on Form 10-K](https://www.sec.gov/ix?doc=/Archives/edgar/data/1261654/000126165422000105/uti-20220930.htm)</u>.

The unaudited condensed consolidated financial statements include the accounts of Universal Technical Institute, Inc. and our wholly-owned subsidiaries. All significant intercompany transactions and balances have been eliminated. The preparation of financial statements in conformity with GAAP requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from these estimates.

------

<u>[**Table of Contents**](#i3fd8c9cc921945018616af2cd8eacdac_7)</u>

**UNIVERSAL TECHNICAL INSTITUTE, INC. AND SUBSIDIARIES**

**NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS**

(In thousands, except per share amounts)

(Unaudited)

Other than described below, there have been no material changes or developments in our significant accounting policies or evaluation of accounting estimates and underlying assumptions or methodologies from those disclosed in Note 2 of our <u>[2022 Annual Report on Form 10-K](https://www.sec.gov/ix?doc=/Archives/edgar/data/1261654/000126165422000105/uti-20220930.htm)</u>.

***New Significant Accounting Policy for Retail Installment Contract Receivables***

Concorde currently and historically offers certain students retail installment contracts for payment of their tuition that is not covered by federal student financial aid or other funding sources. The retail installment contracts are due to Concorde from current and former students and are generally due over a period of one to two years and bear interest ranging from 0 percent to 15 percent. Due to the fact that there is no interest imposed on certain of the retail installment contracts, primarily while students are actively completing their selected programs, we calculate the imputed interest expense on the retail installment contracts. However, the imputed interest expense is not considered material for such retail installment contracts and therefore not recorded. Retail installment contract receivables are recorded at amortized cost less an allowance for credit losses that are not expected to be recovered. The allowance for credit losses is recognized at inception and is reassessed each reporting period. The short-term portion of the retail installment contract receivable and related allowance for credit losses are included in "Receivables, net" while the long-term portion of the retail installment contract receivable and related allowance for credit losses is presented in "Other assets" on our condensed consolidated balance sheet.

***Reclassifications***

As previously noted, as a result of the Concorde Acquisition, beginning with this reporting period we have two reportable segments: UTI and Concorde. Additionally, "Corporate" includes corporate related expenses that are not allocated to either the UTI or Concorde reportable segments. The segment disclosures presented in Note 19 for the three months ended December 31, 2021 have been revised from the prior year presentation to reflect the new reportable segments.

Additionally, starting with the three months ended December 31, 2022, we have reclassified "Accrued tool sets" into "Accounts payable and other accrued expenses" for reporting purposes. As of September 30, 2022, $3.2 million was reclassified from "Accrued tool sets" to "Accounts payable and other accrued expenses" on the condensed consolidated balance sheet for comparable presentation. The breakout of accrued tool sets is now disclosed in Note 12. Further, the activity related to the accrued tool sets balance is now reported in the "Accounts payable and other accrued expenses" line on the condensed consolidated statement of cash flows for the three months ended December 31, 2022. We reclassified $0.5 million from "Accrued tool sets" to "Accounts payable and other accrued expenses" on the condensed consolidated statement of cash flow for the three months ended December 31, 2021 for comparable presentation.

**Note 3** - **Recent Accounting Pronouncements**

***Effective in Fiscal 2023***

In March 2020, the FASB issued ASU 2020-04, *Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting* ("ASU 2020-04"), which provides optional expedients and exceptions for applying GAAP to contract modifications, hedging relationships and other transactions affected by reference rate reform, if certain criteria are met. This new guidance only applies to contracts and other transactions that reference London Interbank Offered Rate ("LIBOR") or another reference rate expected to be discontinued due to reference rate reform. An entity may elect to apply the amendments for contract modifications as of any date from the beginning of an interim period that includes or is subsequent to March 12, 2020, or prospectively from a date within an interim period that includes or is subsequent to March 12, 2020, up to the date that the financial statements are available to be issued. The amendments in ASU 2020-04 do not apply to contract modifications made after December 31, 2022. Given the interest rate for our Avondale term loan (which is further described in Note 13) references LIBOR, we are currently evaluating the new reference rate reform practical expedients and will consider adopting this guidance when we are required to modify our contract for the discontinuation of LIBOR. In December 2022, the FASB issued ASU 2022-06 *Reference Rate Reform (Topic 848): Deferral of the Sunset date of Topic 848* (ASU 2022-06), the amendment in this update defers the sunset date of Topic 848 from December 31, 2022, to December 31, 2024, after which entities will no longer be permitted to apply the relief in Topic 848.

------

<u>[**Table of Contents**](#i3fd8c9cc921945018616af2cd8eacdac_7)</u>

**UNIVERSAL TECHNICAL INSTITUTE, INC. AND SUBSIDIARIES**

**NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS**

(In thousands, except per share amounts)

(Unaudited)

**Note 4 - Acquisitions**

***Concorde Career Colleges***

On December 1, 2022, we completed the Concorde Acquisition. Concorde operates 17 campuses across eight states with approximately 7,600 students, and offers its programs via in-person, hybrid and online formats. Concorde offers more than 20 programs across the allied health, dental, nursing, patient care, and diagnostic fields. The acquisition expands our portfolio of offerings into the higher-growth healthcare arena and creates the opportunity to bring workforce educational solutions to a broader array of students and employers.

Under the terms of the Stock Purchase Agreement (the "Purchase Agreement"), dated May 3, 2022, by and among the Company, Concorde, Liberty Partners Holdings 28, L.L.C., a Delaware limited liability company, and Liberty Investment IIC, LLC, a Delaware limited liability company (each a "Seller," and collectively, the "Sellers"); and Liberty Partners L.P., a Delaware limited partnership, in its capacity as a representative of the Sellers, we acquired all of the issued and outstanding shares of capital stock of Concorde for a base purchase price of $50.0 million, less $1.3 million of net adjustments, for total cash consideration paid of $48.7 million. The final cash consideration paid is subject to closing working capital and other customary adjustments. As a result of the transactions contemplated by the Purchase Agreement, Concorde is now a wholly-owned subsidiary of the Company. We funded the consideration paid for the Concorde Acquisition by the Credit Facility entered into on November 18, 2022. (See Note 13 for further details on the Credit Facility)

In connection with the Concorde Acquisition, we incurred total transaction costs of $3.8 million, of which $3.0 million was incurred during the year ended September 30, 2022 and $0.8 million was incurred during the three months ended December 31, 2022. These costs are included in "Selling, general and administrative" expenses in the condensed consolidated statements of operations for the applicable period.

*Allocation of the purchase price*

Under the acquisition method of accounting, the total purchase price was allocated to the identifiable assets acquired and the liabilities assumed based on our preliminary valuation estimates of the fair values as of the acquisition date. The fair value and allocation of the business combination are preliminary, are based upon management's best estimates and assumptions, and are subject to future revision. We will continue our analysis under the provisions of ASC 805 which allows companies one year to complete acquisition related adjustments which may result in potential adjustments to the carrying value of the respective recorded assets and liabilities, and the determination of any residual amount that will be allocated to goodwill.

The preliminary allocation of the purchase price at December 1, 2022 is summarized as follows:

---

| | |
|:---|:---|
| **Assets acquired:** | |
| &nbsp;&nbsp;Cash and cash equivalents | $30064 |
| &nbsp;&nbsp;Restricted cash | 1689 |
| &nbsp;&nbsp;Accounts receivable, net | 10814 |
| &nbsp;&nbsp;Prepaid expenses | 3490 |
| &nbsp;&nbsp;Other current assets | 828 |
| &nbsp;&nbsp;Property and equipment | 26829 |
| &nbsp;&nbsp;Right-of-use assets for operating leases | 71912 |
| &nbsp;&nbsp;Goodwill | 10133 |
| &nbsp;&nbsp;Intangible assets | 4800 |
| &nbsp;&nbsp;Deferred tax assets | 3799 |
| &nbsp;&nbsp;Other assets | 4997 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total assets acquired | $169355 |

---

------

<u>[**Table of Contents**](#i3fd8c9cc921945018616af2cd8eacdac_7)</u>

**UNIVERSAL TECHNICAL INSTITUTE, INC. AND SUBSIDIARIES**

**NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS**

(In thousands, except per share amounts)

(Unaudited)

---

| | |
|:---|:---|
| **Less: Liabilities assumed** | |
| &nbsp;&nbsp;Accounts payable and accrued expenses | $15762 |
| &nbsp;&nbsp;Deferred revenue | 16471 |
| &nbsp;&nbsp;Operating lease liability, current portion | 11720 |
| &nbsp;&nbsp;Long-term debt, current portion <sup>(1)</sup> | 630 |
| &nbsp;&nbsp;Other current liabilities | 208 |
| &nbsp;&nbsp;Long-term debt <sup>(1)</sup> | 5037 |
| &nbsp;&nbsp;Operating lease liability | 70801 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total liabilities assumed | 120629 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net assets acquired | $48726 |

---

(1)&nbsp;&nbsp;&nbsp;&nbsp;Long-term debt consists of one lease classified as a finance lease under ASC 842.

Due to the timing of the acquisition, the following are considered preliminary and are subject to change:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• amounts for intangible assets, property and equipment, other current assets, current liabilities, and other long-term liabilities pending finalization of the valuation;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• amounts for operating and finance lease assets and liabilities pending finalization of the valuation due to changes in the incremental borrowing rates;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• amounts for income tax liabilities, pending finalization of estimates and assumptions in respect of certain tax aspects of the transaction; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• amount of goodwill pending the completion of the valuation of the assets acquired and liabilities assumed.

The Company will finalize these amounts no later than one year from the acquisition date, once it obtains the information necessary to complete the measurement process. Any changes resulting from facts and circumstances that existed as of the acquisition date may result in adjustments to the preliminary amounts disclosed above which may impact the reported results in the period those adjustments are identified.

The goodwill of $10.1 million, which represents the excess of the purchase price over the fair value of the net assets acquired, was all assigned to the Concorde reporting unit and reportable segment (see Note 19). None of the goodwill is expected to be deductible for tax purposes. Factors that contributed to a purchase price resulting in the recognition of goodwill includes Concorde's strategic fit into our growth and diversification strategy, which is focused on offering a broader array of high-quality, in-demand workforce education solutions which both prepare students for a variety of careers in fast-growing fields and help close the country's skills gap by leveraging key industry partnerships.

The purchase price allocation requires subjective estimates that, if incorrectly estimated, could be material to our condensed consolidated financial statements including the amount of depreciation and amortization expense. The fair value of the property and equipment was estimated using the cost and market approaches as of the valuation date. The fair value of the leases were estimated using the income and market approaches to determine if there was any favorable or unfavorable terms in place. The intangible assets acquired, which primarily consists of the accreditations and regulatory approvals, trademarks and trade names, and curriculum, were valued using different valuation techniques depending upon the nature of the intangible asset acquired, all of which are considered level 3 as defined in Note 7. The accreditations and regulatory approvals were valued using the multi-period excess earnings method ("MPEEM") under the income approach. The MPEEM is a variation of discounted cash-flow analysis. Rather than focusing on the whole entity, the MPEEM isolates the cash flows that can be associated with a single intangible asset and measures fair value by discounting them to present value. The trademarks and trade names were valued using the relief from royalty method. The value of the trade name encompasses all items necessary to generate revenue utilizing the trade name. The curriculum was valued using the cost approach. The table below presents a summary of the intangible assets acquired and the useful lives of these assets:

------

<u>[**Table of Contents**](#i3fd8c9cc921945018616af2cd8eacdac_7)</u>

**UNIVERSAL TECHNICAL INSTITUTE, INC. AND SUBSIDIARIES**

**NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS**

(In thousands, except per share amounts)

(Unaudited)

---

| | | |
|:---|:---|:---|
| **Intangible Asset** | **Useful life** | **Amount** |
| Accreditations and regulatory approvals | Indefinite | $2800 |
| Trademarks and trade names | 10 years | 500 |
| Curriculum | 5 years | 1500 |
| &nbsp;&nbsp;&nbsp;&nbsp; Total |  | $4800 |

---

See Note 9 and Note 10 and for additional details on goodwill and intangible assets.

*Student receivables*

When financial assets are acquired in connection with a business combination we evaluate whether those acquired financial assets have experienced a more-than-insignificant deterioration in credit quality since origination. Financial assets acquired with evidence of such credit deterioration are referred to as purchased credit deteriorated ("PCD") assets and reflect the acquirer's assessment at the acquisition date. The student receivables acquired in the Concorde Acquisition were reviewed to determine if any had experienced a more-than-insignificant deterioration in credit quality since origination. Student receivables of approximately $2.3 million met the established criteria to indicate a more-than an insignificant deterioration in credit quality and were identified as PCD assets. Using our best estimate of projected losses over the term of the contracts, we calculated an allowance for credit losses on these PCD assets of approximately $1.0 million.

*Pro forma financial information*

The following unaudited pro forma financial information summarizes our results of operations as though the acquisition occurred on October 1, 2022:

---

| | | |
|:---|:---|:---|
| | **Three Months Ended**<br>**December 31, 2022** | **Three Months Ended**<br>**December 31, 2021** |
| Revenue | $156025 | $155196 |
| Net income | 2941 | 17193 |

---

The unaudited pro forma financial information includes adjustments to reflect the additional amortization that would have been charged assuming the fair value adjustments to intangible assets and the finance lease asset had been applied from October 1, 2021, with the related tax effects. The unaudited pro forma financial information also includes adjustments to reflect the additional interest expense on the new revolving credit facility issued to fund the acquisition (see Note 13 for further details on the Credit Facility). Lastly, the unaudited pro forma financial information includes adjustments to reflect the reduction in depreciation expense assuming the fair value adjustments to property and equipment assets had been applied from October 1, 2021.

This unaudited pro forma financial information is for informational purposes only. It does not reflect the integration of the business or any synergies or incremental costs that may result from the acquisition. As such, it is not indicative of the results of operations that would have been achieved had the acquisition been consummated on October 1, 2022. In addition, the unaudited pro forma financial information amounts are not indicative of future operating results.

***MIAT College of Technology***

On November 1, 2021, using available operating cash, we acquired all of the issued and outstanding shares of capital stock of MIAT for $26.0 million base purchase price plus $2.8 million working capital surplus for total cash consideration paid of $28.8 million. MIAT is a post-secondary school that offers vocational and technical certificates and degrees across aviation maintenance, energy technology, wind energy technology, robotics and automation, non-destructive testing, heating ventilation air conditioning and refrigeration, and welding disciplines.

------

<u>[**Table of Contents**](#i3fd8c9cc921945018616af2cd8eacdac_7)</u>

**UNIVERSAL TECHNICAL INSTITUTE, INC. AND SUBSIDIARIES**

**NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS**

(In thousands, except per share amounts)

(Unaudited)

The acquisition, as part of our growth and diversification strategy, allows us to expand MIAT programs throughout UTI brand campuses and extend UTI's presence and programs into the Canton, Michigan market where MIAT has been for over 50 years. Other expected synergies include operating and purchasing cost efficiencies and broadening the opportunity for student growth at the acquired MIAT campuses by leveraging our high school and national marketing and admissions infrastructure.

In connection with this acquisition, we incurred total transaction costs of $1.7 million of which $0.9 million were incurred during the year ended September 30, 2022 and $0.8 million during the year ended September 30, 2021. These costs are included in "Selling, general and administrative" expenses in the condensed consolidated statements of operations for the applicable period.

The final allocation of the purchase price at November 1, 2021 is summarized as follows:

---

| | |
|:---|:---|
| **Assets acquired:** | |
| &nbsp;&nbsp;Cash and cash equivalents | $2301 |
| &nbsp;&nbsp;Accounts receivable, net | 3230 |
| &nbsp;&nbsp;Prepaid expenses | 268 |
| &nbsp;&nbsp;Other current assets | 507 |
| &nbsp;&nbsp;Property and equipment | 3043 |
| &nbsp;&nbsp;Goodwill | 8637 |
| &nbsp;&nbsp;Intangible assets | 16200 |
| &nbsp;&nbsp;Right-of-use assets for operating leases | 14979 |
| &nbsp;&nbsp;Other assets | 314 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total assets acquired | $49479 |
| **Less: Liabilities assumed** |  |
| &nbsp;&nbsp;Accounts payable and accrued expenses | $1720 |
| &nbsp;&nbsp;Deferred revenue | 1843 |
| &nbsp;&nbsp;Operating lease liability, current portion | 817 |
| &nbsp;&nbsp;Deferred tax liabilities, net | 1975 |
| &nbsp;&nbsp;Operating lease liability | 14216 |
| &nbsp;&nbsp;Other liabilities | 93 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total liabilities assumed | 20664 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net assets acquired | $28815 |

---

The goodwill of $8.6 million arising from the acquisition consists largely of the growth and operating synergies expected from integrating MIAT into UTI. The total amount of goodwill expected to be deductible for tax purposes is approximately $0.6 million. See Note 9 for additional details on goodwill.

The accreditations and regulatory approvals were valued using the multi-period excess earnings method ("MPEEM") under the income approach. The trademarks and trade names were valued using the relief from royalty method. The curriculum was valued using the cost approach. The table below presents a summary of the intangible assets acquired and the useful lives of these assets:

------

<u>[**Table of Contents**](#i3fd8c9cc921945018616af2cd8eacdac_7)</u>

**UNIVERSAL TECHNICAL INSTITUTE, INC. AND SUBSIDIARIES**

**NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS**

(In thousands, except per share amounts)

(Unaudited)

---

| | | |
|:---|:---|:---|
| **Intangible Asset** | **Useful life** | **Amount** |
| Accreditations and regulatory approvals | Indefinite | $12800 |
| Trademarks and trade names <sup>(1)</sup> | Indefinite | 3000 |
| Curriculum | 5 years | 400 |
| &nbsp;&nbsp;&nbsp;&nbsp; Total |  | $16200 |

---

(1) &nbsp;&nbsp;&nbsp;&nbsp;During the fourth quarter of 2022, in conjunction with our growth and diversification initiatives, we completed a branding study and determined that the useful life of the MIAT trademarks and trade name was no longer indefinite and a four-year finite useful life was more appropriate. We completed the required impairment testing when changing from an indefinite to a finite useful life for an intangible asset and determined that the carrying value of the MIAT trademarks and trade name exceeded its fair value. We determined the fair value of intangible asset to be $1.0 million as of September 30, 2022 using the relief from royalty method and recorded an intangible asset impairment charge of $2.0 million during the year ended September 30, 2022.

Pro forma financial information is not presented as the fiscal 2021 revenues and earnings of MIAT were not material to our condensed consolidated statements of operations. MIAT is included in the "UTI" reporting unit and reportable segment disclosed in Note 19 on Segments.

**Note 5** - **Revenue from Contracts with Customers**

***Nature of Goods and Services***

Revenues across UTI and Concorde consist primarily of student tuition and fees derived from the programs we provide after reductions are made for discounts and scholarships that we sponsor and for refunds for students who withdraw from our programs prior to specified dates. We apply the five-step model outlined in ASC 606. Tuition and fee revenue is recognized ratably over the term of the course or program offered.

The majority of the UTI programs are designed to be completed in 36 to 90 weeks while the MIAT programs are completed in 28 to 96 weeks. The UTI advanced training programs range from 12 to 23 weeks in duration. UTI also provides dealer technician training or instructor staffing services to manufacturers. Revenues are recognized as transfer of the services occurs.

The majority of Concorde's core programs are nine to ten months in duration and are billed in full at the start of the program. Clinical programs are 12 to 24 month programs that are billed by academic term. Clinical programs may have up to nine academic terms that last two to three months.

In addition to revenue from tuition and fees, UTI and Concorde derive supplemental revenues from sales of textbooks and program supplies and other revenues, which are recognized as the transfer of goods or services occurs. Deferred revenue represents the excess of tuition and fee payments received as compared to tuition and fees earned and is reflected as a current liability in our condensed consolidated balance sheets because it is expected to be earned within the next 12 months.

All of our revenues are generated within the United States. The impact of economic factors on the nature, amount, timing and uncertainty of revenue and cash flows is consistent across our various programs for both UTI and Concorde. See Note 19 for disaggregated segment revenue information.

***Proprietary Loan Program Notes Receivable***

Certain UTI students participate in a proprietary loan program that extends repayment terms for their tuition beyond the time that they are in school. We purchase said loans from the lender. Based on historical collection rates, we believe at least a portion of these loans are collectible. Accordingly, we recognize tuition and loan origination fees financed by the loan and any related interest revenue under the effective interest method required under the loan based on the amount we expect to collect, and we recognize these revenues ratably over the term of the course or program offered. These amounts are presented as "Notes receivable, current portion" and "Notes receivable, less current portion" on our condensed consolidated balance sheet.

------

<u>[**Table of Contents**](#i3fd8c9cc921945018616af2cd8eacdac_7)</u>

**UNIVERSAL TECHNICAL INSTITUTE, INC. AND SUBSIDIARIES**

**NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS**

(In thousands, except per share amounts)

(Unaudited)

***Retail Installment Contract Receivables***

Concorde currently and historically offers certain students retail installment contracts for payment of their tuition that are not covered by federal student financial aid or other funding sources. The retail installment contracts are due to Concorde from current and former students and are generally due over a period of one to two years and bear interest ranging from 0 percent to 15 percent. Due to the fact that there is no interest imposed on certain of the retail installment contracts, primarily while students are actively completing their selected programs, we calculate the imputed interest expense on the retail installment contracts. However, the imputed interest expense is not considered material for such retail installment contracts and therefore not recorded. The short-term portion of the retail installment contract receivable and related allowance for credit losses are included in "Receivables, net" while the long-term portion of the retail installment contract receivable and related allowance for credit losses is presented in "Other assets" on our condensed consolidated balance sheet.

***Contract Balances***

Contract assets primarily relate to our rights to consideration for a student's progress through our training program in relation to our services performed but not billed at the reporting date. The contract assets are transferred to the receivables when the rights become unconditional. Currently, we do not have any contract assets that have not transferred to a receivable. Our deferred revenue is considered a contract liability and primarily relates to our enrollment agreements where we received payments for tuition, but we have not yet delivered the related training programs to satisfying the related performance obligations. The advance consideration received from students or Title IV funding is deferred revenue until the training program has been delivered to the students.

The following table provides information about receivables and deferred revenue resulting from our enrollment agreements with students:

---

| | | |
|:---|:---|:---|
| | **December 31, 2022** | **September 30, 2022** |
| Receivables <sup>(1)</sup> | $56234 | $46826 |
| Deferred revenue | 75328 | 54223 |

---

(1) &nbsp;&nbsp;&nbsp;&nbsp;Receivables includes tuition receivables, retail installment contract receivables and notes receivable, both current and long term.

During the three months ended December 31, 2022, the deferred revenue balance included decreases for revenues recognized during the period and increases related to new students who started their training programs during the period and the addition of deferred revenue from the Concorde Acquisition.

**Note 6 - Investments**

In July 2022, we invested a portion of our cash and cash equivalents in short-term investments which primarily consist of corporate and municipal bonds with a minimum credit rating of A. We had the ability and intention to hold these investments until maturity and therefore classified these investments as held-to-maturity and recorded them at amortized cost and presented them in "Held-to-maturity investments" on our consolidated balance sheet as of September 30, 2022. As of December 31, 2022, there were no outstanding held-to-maturity investments as all of the securities matured and there were no new purchases of held-to-maturity investments during the three months ended December 31, 2022.

The amortized cost, gross unrealized gains or losses, and fair value of investments classified as held-to-maturity at September 30, 2022 were as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **September 30, 2022** | **September 30, 2022** | **September 30, 2022** | **September 30, 2022** |
| | | **Gross Unrealized** | **Gross Unrealized** | |
|<br>**Due in less than 1 year:** |<br>**Amortized Cost** | **Gains** | **Losses** | **Estimated Fair**<br>**Market Value** |
| &nbsp;&nbsp;&nbsp;&nbsp;Corporate and municipal bonds | $28918 | $— | $(19) | $28899 |

---

------

<u>[**Table of Contents**](#i3fd8c9cc921945018616af2cd8eacdac_7)</u>

**UNIVERSAL TECHNICAL INSTITUTE, INC. AND SUBSIDIARIES**

**NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS**

(In thousands, except per share amounts)

(Unaudited)

Investments are exposed to various risks, including interest rate, market and credit risk. As a result, it is possible that changes in the values of these investments may occur and that such changes could affect the amounts reported in the condensed consolidated financial statements.

**Note 7 - Fair Value Measurements**

The accounting framework for determining fair value includes a hierarchy for ranking the quality and reliability of the information used to measure fair value, which enables the reader of the financial statements to assess the inputs used to develop those measurements. The fair value hierarchy consists of three tiers:

*Level 1:&nbsp;&nbsp;&nbsp;&nbsp;*Defined as quoted market prices in active markets for identical assets or liabilities.

*Level 2:&nbsp;&nbsp;&nbsp;&nbsp;*Defined as inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices for similar assets or liabilities, quoted prices in markets that are not active, model-based valuation techniques for which all significant assumptions are observable in the market or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.

*Level 3:&nbsp;&nbsp;&nbsp;&nbsp;*Defined as unobservable inputs that are not corroborated by market data.

Any transfers of investments between levels occurs at the end of the reporting period. Assets measured or disclosed at fair value on a recurring basis consisted of the following:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | | **Fair Value Measurements Using** | **Fair Value Measurements Using** | **Fair Value Measurements Using** |
| |<br>**December 31, 2022** | **Quoted Prices<br>in Active<br>Markets for<br>Identical Assets<br>(Level 1)** | **Significant<br>Other<br>Observable<br>Inputs<br>(Level 2)** | **Significant<br>Unobservable<br>Inputs<br>(Level 3)** |
| Money market funds<sup>(1)</sup> | $52768 | $52768 | $— | $— |
| Notes receivable<sup>(2)</sup> | 36494 |  |  | 36494 |
| Total assets at fair value on a recurring basis | $89262 | $52768 | $— | $36494 |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
| | | **Fair Value Measurements Using** | **Fair Value Measurements Using** | **Fair Value Measurements Using** |
| |<br>**September 30, 2022** | **Quoted Prices<br>in Active<br>Markets for<br>Identical Assets<br>(Level 1)** | **Significant<br>Other<br>Observable<br>Inputs<br>(Level 2)** | **Significant<br>Unobservable<br>Inputs<br>(Level 3)** |
| Money market funds<sup>(1)</sup> | $23439 | $23439 | $— | $— |
| Notes receivable<sup>(2)</sup> | 35872 |  |  | 35872 |
| Corporate bonds, municipal bonds, and other<sup>(3)</sup> | 28899 | 28899 |  |  |
| Total assets at fair value on a recurring basis | $88210 | $52338 | $— | $35872 |

---

(1) Money market funds and other highly liquid investments with maturity dates less than 90 days are reflected as "Cash and cash equivalents" in our condensed consolidated balance sheet as of December 31, 2022 and September 30, 2022.

(2) Notes receivable relate to our proprietary loan program and are reflected as "Notes receivable, current portion" and "Notes receivable, less current portion" in our consolidated balance sheets as of December 31, 2022 and September 30, 2022

(3) Corporate bonds, municipal bonds and other are reflected as "Held-to-maturity investments" in our consolidated balance sheet as of September 30, 2022.

------

<u>[**Table of Contents**](#i3fd8c9cc921945018616af2cd8eacdac_7)</u>

**UNIVERSAL TECHNICAL INSTITUTE, INC. AND SUBSIDIARIES**

**NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS**

(In thousands, except per share amounts)

(Unaudited)

**Note 8** - **Property and Equipment, net**

Property and equipment, net consisted of the following:

---

| | | | |
|:---|:---|:---|:---|
| | **Depreciable<br>Lives (in years)** | **December 31, 2022** | **September 30, 2022** |
| Land |  | $16603 | $16603 |
| Buildings and building improvements | 3-30 | 126373 | 126244 |
| Leasehold improvements | 1-20 | 107440 | 86751 |
| Training equipment | 3-10 | 106240 | 96907 |
| Office and computer equipment | 3-10 | 36238 | 31900 |
| Curriculum development | 5 | 20200 | 20130 |
| Software developed for internal use | 1-5 | 12307 | 12150 |
| Vehicles | 5 | 1406 | 1458 |
| Right-of-use assets for finance leases | 2-3 | 2976 | 215 |
| Construction in progress |  | 5711 | 16359 |
|  |  | 435494 | 408717 |
| Less: Accumulated depreciation and amortization |  | (194658) | (194425) |
|  |  | $240836 | $214292 |

---

Depreciation expense related to property and equipment was $5.1 million for the three months ended December 31, 2022, and $3.7 million for the three months ended December 31, 2021.

**Note 9** - **Goodwill**

Our goodwill balance of $27.0 million as of December 31, 2022 represents the excess of the cost of an acquired business over the estimated fair values of the assets acquired and liabilities assumed. The changes in the carrying value of goodwill are presented in the table below.

---

| | | |
|:---|:---|:---|
| | **December 31, 2022** | **September 30, 2022** |
| Balance at beginning of period | $16859 | $16859 |
| &nbsp;&nbsp;Additions to Goodwill for acquisition of Concorde | 10133 |  |
| Balance at end of period | $26992 | $16859 |

---

Of the $27.0 million recorded as goodwill as of December 31, 2022, $10.1 million resulted from the acquisition of Concorde, $8.6 million relates to the acquisition of MIAT as of November 1, 2021, and $8.2 million resulted from the acquisition of our motorcycle and marine education business in Orlando, Florida in 1998. As indicated in Note 1, as a result of the Concorde Acquisition, beginning with this reporting period we have two reportable segments. Prior to this reporting period, all goodwill related to our Postsecondary Education reportable operating segment. The table below summarizes the goodwill balance by reportable segment:

---

| | | |
|:---|:---|:---|
| | **December 31, 2022** | **September 30, 2022** |
| UTI | $16859 | $16859 |
| Concorde | 10133 | $— |
| &nbsp;&nbsp;Total | $26992 | $16859 |

---

Goodwill is reviewed at least annually for impairment, which may result from the deterioration in the operating performance of the acquired businesses, adverse market conditions, adverse changes in applicable laws or regulations and a variety of

------

<u>[**Table of Contents**](#i3fd8c9cc921945018616af2cd8eacdac_7)</u>

**UNIVERSAL TECHNICAL INSTITUTE, INC. AND SUBSIDIARIES**

**NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS**

(In thousands, except per share amounts)

(Unaudited)

other circumstances. Our goodwill is tested annually for impairment as of August 1 and more frequently if events or circumstances lead to a determination that it is more likely than not that the fair value of a report unit is less than its carrying amount. There were no indicators of goodwill impairment as of December 31, 2022.

**Note 10 - Intangible Assets**

The following table provides the gross carrying value, accumulated amortization, net book value and remaining useful life for those intangible assets that are subject to amortization as of December 31, 2022:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Gross Carrying Value** | **Accumulated Amortization** | **Net Book Value** | **Weighted Average Remaining Useful Life (Years)** |
| Accreditations and regulatory approvals | $15600 | $— | $15600 | Indefinite |
| Trademarks, trade names and other | 1942 | (429) | 1513 | 5.69 |
| Curriculum | 1900 | (118) | 1782 | 4.73 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total | $19442 | $(547) | $18895 | 5.17 |

---

The following table provides the gross carrying value, accumulated amortization, net book value and remaining useful life for those intangible assets that are subject to amortization as of December 31, 2021:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Gross Carrying Value** | **Accumulated Amortization** | **Net Book Value** | **Weighted Average Remaining Useful Life (Years)** |
| Accreditations and regulatory approvals - MIAT | $12800 | $— | $12800 | Indefinite |
| Trademarks and trade names - MIAT | 3000 |  | 3000 | Indefinite |
| Curriculum - MIAT | 400 | (13) | 387 | 4.83 |
| Non-compete agreement and trade name | 442 | (327) | 115 | 3.33 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total | $16642 | $(340) | $16302 | 4.47 |

---

Amortization expense for the three months ended December 31, 2022 and 2021 was $120 thousand and $20 thousand, respectively. The increase in the amortization expense during the three months ended December 31, 2022, which is not considered material to the condensed consolidated financial statements, was due to the intangible assets acquired with the Concorde Acquisition.

Of the $19.4 million recorded as intangible assets as of December 31, 2022, $4.8 million relates to the Concorde Acquisition, $14.2 million relates to the MIAT acquisition completed on November 1, 2021, and $0.4 million relates to previously recorded non-compete agreements and trade names. The remaining weighted average useful lives shown are calculated based on the net book value and remaining amortization period of each respective intangible asset. Amortization is computed using the straight-line method based on estimated useful lives of the related assets. Our indefinite-lived intangible assets are reviewed at least annually for impairment as of August 1, or more frequently if there are indicators of impairment. There were no indicators of impairment for our indefinite-lived intangible assets as of December 31, 2022.

**Note 11** - **Leases**

As of December 31, 2022, we leased 29 of our 33 campuses and two corporate office locations under non-cancelable operating leases, some of which contain escalation clauses and requirements to pay other fees associated with the leases. The facility leases have original lease terms ranging from 5 to 20 years and expire at various dates through 2036. In addition, the leases commonly include lease incentives in the form of rent abatements and tenant improvement allowances. We sublease

------

<u>[**Table of Contents**](#i3fd8c9cc921945018616af2cd8eacdac_7)</u>

**UNIVERSAL TECHNICAL INSTITUTE, INC. AND SUBSIDIARIES**

**NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS**

(In thousands, except per share amounts)

(Unaudited)

certain portions of unused building space to third parties, which as of December 31, 2022, resulted in minimal income. All of the leases, other than those that may qualify for the short-term scope exception of 12 months or less, are recorded on our condensed consolidated balance sheets.

Some of the facility leases are subject to annual changes in the Consumer Price Index ("CPI"). While lease liabilities are not remeasured as a result of changes to the CPI, changes to the CPI are treated as variable lease payments and recognized in the period in which the obligation for those payments was incurred. Many of our lease agreements include options to extend the lease, which we do not include in our minimum lease terms unless they are reasonably certain to be exercised. There are no early termination with penalties, residual value guarantees, restrictions or covenants imposed by our facility leases.

The components of lease expense are included in "Educational services and facilities" and "Selling, general and administrative" on the condensed consolidated statement of operations, with the exception of interest on lease liabilities, which is included in "Interest expense."

The components of lease expense during the three months ended December 31, 2022 and 2021 were as follows:

---

| | | |
|:---|:---|:---|
| | **Three Months Ended December 31,** | **Three Months Ended December 31,** |
|<br>**Lease Expense** | **2022** | **2021** |
| Operating lease expense<sup>(1)</sup> | $5704 | $6363 |
| Finance lease expense: |  |  |
| &nbsp;&nbsp;Amortization of leased assets | 198 | 18 |
| &nbsp;&nbsp;Interest on lease liabilities | 87 | 1 |
| Variable lease expense | 1950 | 1091 |
| Sublease income | (32) | (59) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total net lease expense | $7907 | $7414 |

---

(1)&nbsp;&nbsp;&nbsp;&nbsp;Excludes the expense for short-term leases not accounted for under ASC 842, which was not significant for the three months ended December 31, 2022 and 2021.

Supplemental balance sheet, cash flow and other information related to our leases was as follows (in thousands, except lease term and discount rate):

---

| | | | |
|:---|:---|:---|:---|
| **Leases** | **Classification** | **December 31, 2022** | **September 30, 2022** |
| **Assets:** | | | |
| Operating lease assets | Right-of-use assets for operating leases<sup>(1)</sup> | $199947 | $132038 |
| Finance lease assets | Property and equipment, net<sup>(2)</sup> | 2719 | 22 |
| &nbsp;&nbsp;Total leased assets |  | $202666 | $132060 |
| **Liabilities:** |  |  |  |
| Current |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Operating lease liabilities | Operating lease liability, current portion<sup>(1)</sup> | $24206 | $12959 |
| &nbsp;&nbsp;&nbsp;&nbsp;Finance lease liabilities | Long-term debt, current portion | 642 | 23 |
| Noncurrent |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Operating lease liabilities | Operating lease liability<sup>(1)</sup> | 195730 | 129302 |
| &nbsp;&nbsp;&nbsp;&nbsp;Finance lease liabilities | Long-term debt | 4982 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total lease liabilities |  | $225560 | $142284 |

---

------

<u>[**Table of Contents**](#i3fd8c9cc921945018616af2cd8eacdac_7)</u>

**UNIVERSAL TECHNICAL INSTITUTE, INC. AND SUBSIDIARIES**

**NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS**

(In thousands, except per share amounts)

(Unaudited)

(1) &nbsp;&nbsp;&nbsp;&nbsp;As noted in Note 4, during the three months ended December 31, 2022, our right-of-use assets and operating lease liability increased due to the acquisition of Concorde.

(2) &nbsp;&nbsp;&nbsp;&nbsp;Finance lease assets are recorded net of accumulated amortization of $0.3 million and $0.2 million as of December 31, 2022 and September 30, 2022, respectively.

---

| | | |
|:---|:---|:---|
| **Lease Term and Discount Rate** | **December 31, 2022** | **September 30, 2022** |
| Weighted-average remaining lease term (in years): |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Operating leases | 8.43 | 8.92 |
| &nbsp;&nbsp;&nbsp;&nbsp;Finance leases | 6.08 | 0.33 |
| Weighted average discount rate: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Operating leases | 3.58% | 3.91% |
| &nbsp;&nbsp;&nbsp;&nbsp;Finance leases | 9.29% | 3.08% |

---

---

| | | |
|:---|:---|:---|
| | **Three Months Ended December 31,** | **Three Months Ended December 31,** |
|<br>**Supplemental Disclosure of Cash Flow Information and Other Information** | **2022** | **2021** |
| Cash paid for amounts included in the measurement of lease liabilities: |  |  |
| &nbsp;&nbsp;Operating cash flows from operating leases | $4963 | $2567 |
| &nbsp;&nbsp;Financing cash flows from finance leases | 115 | 18 |
| Non-cash activity related to lease liabilities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Lease assets obtained in exchange for new operating lease liabilities <sup>(1)</sup> | $117 | $7457 |
| &nbsp;&nbsp;&nbsp;&nbsp;Lease assets obtained in exchange for new finance lease liabilities |  |  |

---

(1) Excludes the operating leases recorded for the Concorde and MIAT acquisitions discussed in Note 4.

Maturities of lease liabilities were as follows:

---

| | | |
|:---|:---|:---|
| | **As of December 31, 2022** | **As of December 31, 2022** |
|<br>**Years ending September 30,** | **Operating Leases** | **Finance Leases** |
| Remainder of 2023 | $21804 | $854 |
| 2024 | 33160 | 1159 |
| 2025 | 31829 | 1193 |
| 2026 | 30763 | 1229 |
| 2027 | 29301 | 1266 |
| 2028 and thereafter | 108252 | 1743 |
| &nbsp;&nbsp;Total lease payments | 255109 | 7444 |
| Less: interest | (35173) | (1820) |
| &nbsp;&nbsp;Present value of lease liabilities | 219936 | 5624 |
| Less: current lease liabilities | (24206) | (642) |
| &nbsp;&nbsp;Long-term lease liabilities | $195730 | $4982 |

---

------

<u>[**Table of Contents**](#i3fd8c9cc921945018616af2cd8eacdac_7)</u>

**UNIVERSAL TECHNICAL INSTITUTE, INC. AND SUBSIDIARIES**

**NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS**

(In thousands, except per share amounts)

(Unaudited)

**Note 12 - Accounts Payable and Accrued Expenses**

Accounts payable and accrued expenses consisted of the following:

---

| | | |
|:---|:---|:---|
| | **December 31, 2022** | **September 30, 2022** |
| Accounts payable | $13039 | $21746 |
| Accrued compensation and benefits | 27453 | 28430 |
| Other accrued expenses | 19134 | 13328 |
| Accrued tool sets | 3229 | 3176 |
| &nbsp;&nbsp;Total accounts payable and accrued expenses | $62855 | $66680 |

---

**Note 13 - Debt**

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **December 31, 2022** | **December 31, 2022** | **December 31, 2022** | **September 30, 2022** |
| | **Interest Rate** | **Maturity Date** | **Carrying Value of Debt**<sup>(6)</sup> | **Carrying Value of Debt**<sup>(6)</sup> |
| Revolving Credit Facility<sup>(1)</sup> | 6.54% | Nov 2025 | $90000 | $— |
| Avondale Term Loan<sup>(2)</sup> | 6.12% | May 2028 | $29877 | $30083 |
| Lisle Term Loan<sup>(3)</sup> | 6.12% | Apr 2029 | 38000 | 38000 |
| Finance leases<sup>(4)</sup> | 9.29% | Various | 5624 | 23 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total debt |  |  | 163501 | 68106 |
| Debt issuance costs presented with debt <sup>(5)</sup> |  |  | (527) | (568) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total debt, net |  |  | 162974 | 67538 |
| Less: current portion of long-term debt |  |  | (1945) | (1115) |
| Long-term debt |  |  | $161029 | $66423 |

---

(1) &nbsp;&nbsp;&nbsp;&nbsp;Interest on the Revolving Credit Facility (as defined below) accrues at annual rate equal to the SOFR plus a margin of 2.0% and a lender specific spread of 0.15%.

(2)&nbsp;&nbsp;&nbsp;&nbsp;Interest on the Avondale Term Loan (as defined below) accrues at annual rate equal to the LIBOR plus 2.0%.

(3)&nbsp;&nbsp;&nbsp;&nbsp;Interest on the Lisle Term Loan (as defined below) accrues at annual rate equal to the SOFR plus 2.0%.

(4)&nbsp;&nbsp;&nbsp;&nbsp;Our finance leases include finance lease arrangements related to a facility lease and various equipment with a weighted-average annual interest rate of approximately 9.29%. The equipment leases mature in 2023 and the facility lease matures in 2029. See Note 11 for additional details on our finance leases.

(5)&nbsp;&nbsp;&nbsp;&nbsp;The unamortized debt issuance costs as of December 31, 2022 relate to the Avondale Term Loan and the Lisle Term Loan.

(6)&nbsp;&nbsp;&nbsp;&nbsp;Our Credit Facility, Term Loans and finance leases bear interest at rates commensurate with market rates and therefore the respective carrying values approximate fair value (Level 2).

***Revolving Credit Facility***

On November 18, 2022, we entered into a $100.0 million senior secured revolving credit facility with Fifth Third Bank, a national banking association (the "Credit Facility"), which includes a $20.0 million sub facility that is available for letters of credit. The Credit Facility has a term of three years, unless earlier terminated pursuant to the terms and conditions set forth in the credit agreement.

This agreement provides that the revolver will amortize on an interest-only basis during its term with principal able to be borrowed, re-paid and re-borrowed throughout the term of the Facility and with the outstanding principal due and payable at maturity. Advances made under the Credit Facility will bear interest at a floating rate equal to, at our option, either (a) a variable rate equal to the greater of: (i) 3.5%, or (ii) the rate that the lender publicly announces, publishes or designates from time to time as its index rate or prime rate, or any successor rate thereto, in effect at its principal office, or (b) a variable rate

------

<u>[**Table of Contents**](#i3fd8c9cc921945018616af2cd8eacdac_7)</u>

**UNIVERSAL TECHNICAL INSTITUTE, INC. AND SUBSIDIARIES**

**NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS**

(In thousands, except per share amounts)

(Unaudited)

equal to the greater of (i) 0%, or (ii) Term SOFR relating to quotations for one (1) or three (3) months, as selected by us or as otherwise set pursuant to the terms of the credit agreement, as applicable, plus, in the case of any Term SOFR loan, an adjustment equal to 0.10% if the interest period is one (1) month and 0.15% if the interest period is three (3) months. Interest in the case of tranche rate loans will be increased by an applicable margin that varies from 1.75% up to 2.25% based on our then-current total leverage ratio. In executing the Credit Facility, we incurred $0.5 million in debt issuance costs which have been recorded in "Other assets" on the condensed consolidated balance sheet as of December 31, 2022. On November 28, 2022, we drew $90.0 million from the credit facility in support of the closing of the Concorde Acquisition at an interest rate of 6.54%. In December 2022, a $1.8 million letter of credit was issued on the Credit Facility, reducing our availability as of December 31, 2022 to $8.2 million.

We are also subject to certain customary affirmative and negative covenants under the credit agreement for financing generally and for the Credit Facility, including financial covenants such as total leverage ratio, a fixed charge coverage ratio, and a quick ratio. In addition, we are required to maintain a financial responsibility composite score of at least 1.4 as of the end of the fiscal year ending September 30, 2023 and of at least 1.5 as of the end of any fiscal year thereafter. Lastly, we are subject to a "clean off" provision, under which within the first 20 months after our initial draw under the Credit Facility, the amount outstanding on the Credit Facility will not exceed $20.0 million for a single 30 consecutive day period. As of December 31, 2022, we were in compliance with all covenants under our Credit Facility.

***Avondale Term Loan***

In connection with the Avondale, Arizona building purchase in December 2020, we entered into a Credit Agreement with Fifth Third Bank, National Association (the "Avondale Lender") on May 12, 2021 in the maximum principal amount of $31.2 million with a maturity of seven years (the "Avondale Term Loan"). The Avondale Term Loan bears interest at the rate of LIBOR plus 2.0%. Principal and interest payments are due monthly. The Avondale Term Loan is secured by a first priority lien on our Avondale, Arizona property, including all land and improvements. Additionally, on May 12, 2021, we entered into an interest rate swap agreement with the Avondale Lender that effectively fixes the interest rate on 50% of the principal amount of the Avondale Term Loan, or approximately $15.6 million, at 3.5% for the entire loan term. See Note 14 below for further discussion on the interest rate swap.

***Lisle Term Loan***

On April 14, 2022, 2611 (the "Borrower") entered into a new Loan Agreement ("Lisle Loan Agreement") with Valley National Bank (the "Lisle Lender"), to fund the acquisition and retire prior loan agreement with Western Alliance bank, via a term loan in the original principal amount of $38.0 million with a maturity of seven years (the "Lisle Term Loan"). The Lisle Term Loan bears interest at a rate of one-month Secured Overnight Financing Rate ("SOFR") plus 2.0%. The Lisle Term Loan is secured by a mortgage on the Lisle Campus and is guaranteed by the Company. In connection with the Lisle Term Loan, we entered into an interest rate swap agreement with the Lisle Lender that effectively fixes the interest rate on 50% of the principal amount of the Lisle Term Loan, or $19.0 million, at 4.69% for the entire loan term. See Note 14 below for further discussion on the interest rate swap

***Debt Covenants for our Term Loans***

We are subject to certain customary affirmative and negative covenants in connection with our term loans, including, without limitation, certain reporting obligations, certain limitations on restricted payments, limitations on liens, encumbrances and indebtedness and a debt service coverage ratio covenant. Events of default under the Avondale Term Loan and the Lisle Term Loan include, among others, the failure to make payments when due, breach of covenants, and breach of representations or warranties. For further discussion of our debt covenants, see Note 15 on "Debt" included in our <u>[2022 Annual Report on Form 10-K](http://www.sec.gov/ix?doc=/Archives/edgar/data/1261654/000126165422000105/uti-20220930.htm)</u>. As of December 31, 2022, we were in compliance with all term loan debt covenants.

------

<u>[**Table of Contents**](#i3fd8c9cc921945018616af2cd8eacdac_7)</u>

**UNIVERSAL TECHNICAL INSTITUTE, INC. AND SUBSIDIARIES**

**NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS**

(In thousands, except per share amounts)

(Unaudited)

***Debt Maturities***

Scheduled principal payments due on our debt for the remainder of 2023 and for each year through the period ended September 30, 2027, and thereafter were as follows at December 31, 2022:

---

| | | | |
|:---|:---|:---|:---|
| **Maturity** | **Revolving Credit Facility & Term Loans** | **Finance Leases** | **Total** |
| Remainder of 2023 | $886 | $477 | $1363 |
| 2024 | 71672 | 709 | 72381 |
| 2025 | 1763 | 815 | 2578 |
| 2026 | 21836 | 931 | 22767 |
| 2027 | 1909 | 1060 | 2969 |
| Thereafter | 59811 | 1632 | 61443 |
| &nbsp;&nbsp;Subtotal | 157877 | 5624 | 163501 |
| Debt issuance costs presented with debt | (527) |  | (527) |
| &nbsp;&nbsp;Total | $157350 | $5624 | $162974 |

---

**Note 14 - Derivative Financial Instruments**

In the normal course of business, our operations are exposed to market risks, including the effect of changes in interest rates. We may enter into derivative financial instruments to offset these underlying market risks.

On May 12, 2021, in connection with the Avondale Term Loan discussed in Note 13, we entered into an interest rate swap agreement with the Avondale Lender that effectively fixes the interest rate on 50% of the principal amount of the Avondale Term Loan, or approximately $15.6 million, at 3.5% for the entire loan term, or seven years (the "Avondale Swap"). On May 12, 2021, the Avondale Swap was designated as an effective cash flow hedge for accounting and tax purposes.

On April 14, 2022, in connection with the Lisle Term loan discussed in Note 13, we entered into an interest rate swap agreement with the Lisle Lender that effectively fixes the interest rate on 50% of the principal amount of the Lisle Term Loan at 4.69% for the entire loan term, or seven years (the "Lisle Swap"). On April 14, 2022, the Lisle Swap was designated as an effective cash flow hedge for accounting and tax purposes.

Changes in the fair value of derivatives that are designated and qualify as cash flow hedges are recorded in "Accumulated other comprehensive income" on the condensed consolidated balance sheets. For cash flow hedges, we report the effective portion of the gain or loss as a component of "Accumulated other comprehensive income" and reclassify it to "Interest expense" in the condensed consolidated statements of operations over the corresponding period of the underlying hedged item. The ineffective portion of the change in fair value of a derivative financial instrument is recognized in "Interest expense" at the time the ineffectiveness occurs. To the extent the hedged forecasted interest payments on debt related to our interest rate swap is paid off, the remaining balance in "Accumulated other comprehensive income" is recognized in "Interest expense" in the condensed consolidated statements of operations. Of the net amount of the existing gains that are reported in "Accumulated other comprehensive income" as of December 31, 2022, we estimate that $0.9 million will be reclassified to "Interest expense" within the next twelve months. As of December 31, 2022, the notional amount of the Avondale Swap and Lisle Swap was approximately $14.9 million and $19.0 million, respectively.

------

<u>[**Table of Contents**](#i3fd8c9cc921945018616af2cd8eacdac_7)</u>

**UNIVERSAL TECHNICAL INSTITUTE, INC. AND SUBSIDIARIES**

**NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS**

(In thousands, except per share amounts)

(Unaudited)

***Fair Value of Derivative Instruments***

The following table presents the fair value of our Avondale Swap and Lisle Swap (Level 2) which are designated as cash flow hedges and the related classification on the condensed consolidated balance sheet as of December 31, 2022 and September 30, 2022:

---

| | | |
|:---|:---|:---|
| **Interest Rate Swaps** | **December 31, 2022** | **September 30, 2022** |
| Other current assets | $813 | $632 |
| Other assets | 1718 | 2067 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total fair value of assets designated as hedging instruments | $2531 | $2699 |

---

***Effect of Cash Flow Hedge Accounting on the Consolidated Statements of Operations and Accumulated Other Comprehensive Income***

The table below presents the effect of cash flow hedge accounting for our Avondale Swap and Lisle Swap on the condensed consolidated statement of operations and "Accumulated other comprehensive income" for the three months ended December 31, 2022 and 2021:

---

| | | | |
|:---|:---|:---|:---|
| | **Amount of Gain (Loss) Recognized in Other Comprehensive Income (Loss) on Derivative, net of taxes** | **Location of Gain (Loss) Reclassified from Accumulated Other Comprehensive Income (Loss) into Income** | **Amount of Gain (Loss) Reclassified from Accumulated Other Comprehensive Income (Loss) into Income** |
| | **Three Months Ended December 31, 2022** | **Three Months Ended December 31, 2022** | **Three Months Ended December 31, 2022** |
| Avondale Swap and Lisle Swap | $41 | Interest expense | $(128) |
|  | **Three Months Ended December 31, 2021** | **Three Months Ended December 31, 2021** | **Three Months Ended December 31, 2021** |
| Avondale Swap | $118 | Interest expense | $(55) |

---

**Note 15** - **Income Taxes**

Our income tax expense for the three months ended December 31, 2022 was $1.5 million, or 36.5% of pre-tax income, compared to an income tax benefit of $1.3 million, or (10.0)% of pre-tax income, for the three months ended December 31, 2021. The income tax expense for the three months ended December 31, 2022 is primarily driven by non-deductible executive compensation, transaction costs and state and local income and franchise taxes. The income tax benefit recorded during the three months ended December 31, 2021 was primarily comprised of the valuation allowance impact related to the MIAT deferred tax liability for indefinite lived intangibles which were available to offset a portion of our indefinite lived deferred tax assets, offset by current state tax expense.

As of each reporting date, management considers new evidence, both positive and negative, that could affect its view of the future realization of deferred tax assets. During the three months ended March 31, 2022, based in part on our sustained positive earnings in recent quarters, we determined that there was sufficient evidence to meet the more likely than not realizability threshold and support the reversal of a majority of the previously recorded valuation allowance against our deferred tax assets. The release of the valuation allowance resulted in the recognition of certain deferred tax assets on the condensed consolidated balance sheet and a non-cash tax benefit recorded in the condensed consolidated statement of operations for the period. As of December 31, 2022, we continued to maintain a valuation allowance related to certain federal and state attributes which are not expected to be utilized prior to expiration.

------

<u>[**Table of Contents**](#i3fd8c9cc921945018616af2cd8eacdac_7)</u>

**UNIVERSAL TECHNICAL INSTITUTE, INC. AND SUBSIDIARIES**

**NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS**

(In thousands, except per share amounts)

(Unaudited)

**Note 16** - **Commitments and Contingencies** 

***Surety Bonds***

Each of our campuses must be authorized by the applicable state education agency in which the campus is located to operate and to grant certificates, diplomas or degrees to its students. Our campuses are subject to extensive, ongoing regulation by each of these states. Additionally, our campuses are required to be authorized by the applicable state education agencies of certain other states in which our campuses recruit students. Our insurers issue surety bonds for us on behalf of our campuses and admissions representatives with multiple states to maintain authorization to conduct our business. We are obligated to reimburse our insurers for any surety bonds that are paid by the insurers. As of December 31, 2022 and September 30, 2022, the total face amount of these surety bonds was approximately $29.6 million and $20.5 million, respectively. The Concorde Acquisition contributed $4.6 million to the current period amount.

***Legal***

In the ordinary conduct of our business, we are periodically subject to lawsuits, demands in arbitration, investigations, regulatory proceedings or other claims, including, but not limited to, claims involving current or former students, routine employment matters, business disputes and regulatory demands. When we are aware of a claim or potential claim, we assess the likelihood of any loss or exposure. If it is probable that a loss will result and the amount of the loss can be reasonably estimated, we accrue a liability for the loss. When a loss is not both probable and estimable, we do not accrue a liability.

Where a loss is not probable but is reasonably possible, including if a loss in excess of an accrued liability is reasonably possible, we determine whether it is possible to provide an estimate of the amount of the loss or range of possible losses for the claims. We are not currently a party to any material legal proceedings, but note that legal proceedings could, generally, have a material adverse effect on our business, cash flows, results of operations or financial condition.

**Note 17** - **Shareholders' Equity**

***Common Stock***

Holders of our common stock are entitled to receive dividends when and as declared by our Board of Directors and have the right to one vote per share on all matters requiring shareholder approval. On June 9, 2016, our Board of Directors voted to eliminate the quarterly cash dividend on our common stock. Any future common stock dividends require the approval of a majority of the voting power of the Series A Preferred Stock.

***Preferred Stock***

Preferred Stock consists of 10,000,000 authorized preferred shares of $0.0001 par value each. As of December 31, 2022 and September 30, 2022, 675,885 shares of Series A Convertible Preferred Stock ("Series A Preferred Stock") were issued and outstanding, respectively. The liquidation preference associated with the Series A Preferred Stock was $100 per share at December 31, 2022 and September 30, 2022.

Pursuant to the terms of the Certificate of Designations of the Series A Preferred Stock, we may pay a cash dividend on each share of the Series A Preferred Stock at a rate of 7.5% per year on the liquidation preference then in effect ("Cash Dividend"). If we do not pay a Cash Dividend, the liquidation preference shall be increased to an amount equal to the current liquidation preference in effect plus an amount reflecting that liquidation preference multiplied by the Cash Dividend rate then in effect plus 2.0% per year. Cash Dividends are payable semi-annually in arrears on September 30 and March 31 of each year, and begin to accrue on the first day of the applicable dividend period. We accrued Cash Dividends of approximately $1.3 million as of December 31, 2022.

***Share Repurchase Program***

On December 10, 2020, our Board of Directors authorized a new share repurchase plan that would allow for the repurchase of up to $35.0 million of our common stock in the open market or through privately negotiated transactions. This new share repurchase plan replaced the previously authorized plan from fiscal 2012. Any repurchases under this new stock repurchase

------

<u>[**Table of Contents**](#i3fd8c9cc921945018616af2cd8eacdac_7)</u>

**UNIVERSAL TECHNICAL INSTITUTE, INC. AND SUBSIDIARIES**

**NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS**

(In thousands, except per share amounts)

(Unaudited)

program require the approval of a majority of the voting power of our Series A Preferred Stock. We have not repurchased any shares under the share repurchase program, including during the three months ended December 31, 2022.

**Note 18** - **Earnings per Share**

We calculate basic earnings per common share ("EPS") pursuant to the two-class method as a result of the issuance of the Series A Preferred Stock on June 24, 2016. Our Series A Preferred Stock is considered a participating security because, in the event that we pay a dividend or make a distribution on the outstanding common stock, we shall also pay each holder of the Series A Preferred Stock a dividend on an as-converted basis. The two-class method is an earnings allocation formula that determines EPS for common stock and participating securities according to dividend and participation rights in undistributed earnings. Under this method, all earnings, distributed and undistributed, are allocated to common shares and participating securities based on their respective rights to receive dividends. The Series A Preferred Stock is not included in the computation of basic EPS in periods in which we have a net loss, as the Series A Preferred Stock is not contractually obligated to share in our net losses.

Diluted EPS is calculated using the more dilutive of the two-class method or as-converted method. The two-class method uses net income available to common shareholders and assumes conversion of all potential shares other than the participating securities. The as-converted method uses net income and assumes conversion of all potential shares including the participating securities. Dilutive potential common shares include outstanding stock options, unvested restricted share units and convertible preferred stock.

The following table summarizes the computation of basic and diluted EPS under the two-class or as-converted method, as well as the anti-dilutive shares excluded:

---

| | | |
|:---|:---|:---|
| | **Three Months Ended** | **Three Months Ended** |
| | **December 31,** | **December 31,** |
| | **2022** | **2021** |
| **Basic earnings per common share:** |  |  |
| Net income | $2648 | $14822 |
| Less: Preferred stock dividend declared | (1277) | (1323) |
| &nbsp;&nbsp;&nbsp;&nbsp;Net income available for distribution | 1371 | 13499 |
| Income allocated to participating securities | (514) | (5267) |
| &nbsp;&nbsp;&nbsp;&nbsp;Net income available to common shareholders | $857 | $8232 |
| Weighted average basic shares outstanding | 33805 | 32849 |
| Basic income per common share | $0.03 | $0.25 |

---

------

<u>[**Table of Contents**](#i3fd8c9cc921945018616af2cd8eacdac_7)</u>

**UNIVERSAL TECHNICAL INSTITUTE, INC. AND SUBSIDIARIES**

**NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS**

(In thousands, except per share amounts)

(Unaudited)

---

| | | |
|:---|:---|:---|
| | **Three Months Ended** | **Three Months Ended** |
| | **December 31,** | **December 31,** |
| | **2022** | **2021** |
| **Diluted earnings per common share:** |  |  |
| *Method used:* | *Two-class* | *Two-class* |
| Net income available to common shareholders | $857 | $8232 |
| Weighted average basic shares outstanding | 33805 | 32849 |
| Dilutive effect related to employee stock plans | 603 | 723 |
| &nbsp;&nbsp;&nbsp;&nbsp;Weighted average diluted shares outstanding | 34408 | 33572 |
| Diluted income per common share | $0.02 | $0.25 |
| **Anti-dilutive shares excluded:** |  |  |
| Outstanding stock-based grants | 506 | 186 |
| Convertible preferred stock | 20297 | 21021 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total anti-dilutive shares excluded | 20803 | 21207 |
| Dilutive shares under the as-converted method<sup>(1)</sup> | 54705 | 54593 |

---

(1) The dilutive shares under the as-converted method assume conversion of the Series A Preferred Stock and are presented here merely for reference. In a net income position, diluted earnings per share is determined by the more dilutive of the two-class method or the as-converted method.

**Note 19** - **Segment Information**

During the three months ended December 31, 2022, we revised our reportable segments to reflect the manner in which the chief operating decision-maker evaluates performance and allocates resources. As a result of the Concorde Acquisition (as discussed in Note 4), beginning with this reporting period we have two reportable segments as follows:

***UTI:*** UTI operates 16 campuses located in 9 states and offers a wide range of degree and non-degree transportation and skilled trades technical training programs under brands such as Universal Technical Institute, Motorcycle Mechanics Institute, Marine Mechanics Institute, NASCAR Technical Institute, and MIAT College of Technology ("MIAT"). UTI also offers manufacturer specific advanced training programs, which include student-paid electives, at our campuses and manufacturer or dealer sponsored training at certain campuses and dedicated training centers. Lastly, UTI provides dealer technician training or instructor staffing services to manufacturers.

***Concorde:*** Concorde operates across 17 campuses in 8 states, offering degree, non-degree and continuing education programs in the allied health, dental, nursing, patient care and diagnostic fields. Concorde believes in preparing students for their health care careers with practical, hands-on experiences including opportunities to learn while providing care to real patients. Prior to graduation, students will complete a number of hours in a clinical setting or externship, depending upon their program of study.

"Corporate" includes corporate related expenses that are not allocated to the UTI or Concorde reportable segments and is included to reconcile segment results to the condensed consolidated financial statements. These costs were previously allocated across our former "Postsecondary Education" reportable segment and "Other" category based upon compensation expense. Prior periods have been updated to conform to the revised presentation.

------

<u>[**Table of Contents**](#i3fd8c9cc921945018616af2cd8eacdac_7)</u>

**UNIVERSAL TECHNICAL INSTITUTE, INC. AND SUBSIDIARIES**

**NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS**

(In thousands, except per share amounts)

(Unaudited)

Summary information by reportable segment is as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **UTI** | **Concorde** | **Corporate** | **Consolidated** |
| **Three Months Ended December 31, 2022** | | | | |
| Revenues | $105573 | $14431 | $— | $120004 |
| Income (loss) from operations | 16515 | (726) | (11341) | 4448 |
| Depreciation and amortization<sup>(1)</sup> | 4775 | 457 | 16 | 5248 |
| Net income (loss) | 15825 | (734) | (12443) | 2648 |
| **Three Months Ended December 31, 2021** |  |  |  |  |
| Revenues | $105075 | $— | $— | $105075 |
| Income (loss) from operations | 23167 |  | (9589) | 13578 |
| Depreciation and amortization<sup>(1)</sup> | 3663 |  | 16 | 3679 |
| Net income (loss) | 22959 |  | (8137) | 14822 |
| **As of December 31, 2022** |  |  |  |  |
| Total assets | $383349 | $149668 | $215056 | $748073 |
| **As of September 30, 2022** |  |  |  |  |
| Total assets | $436917 | $— | $115994 | $552911 |

---

(1) Includes depreciation of training equipment obtained in exchange for services of $0.2 million for the three months ended December 31, 2022 and 2021, respectively.

**Note 20** - **Government Regulation and Financial Aid**

As discussed at length in our <u>[2022 Annual Report on Form 10-K](http://www.sec.gov/Archives/edgar/data/1261654/000126165421000073/uti-20210930.htm)</u>, our institutions participate in a range of government-sponsored student assistance programs. The most significant of these is the federal student aid programs administered by the U.S. Department of Education ("ED") pursuant to Title IV of the Higher Education Act ("HEA"), commonly referred to as the Title IV Programs. Generally, to participate in the Title IV Programs, an institution must be licensed or otherwise legally authorized to operate in the state where it is physically located, be accredited by an accreditor recognized by ED, be certified as an eligible institution by ED, offer at least one eligible program of education, and comply with other statutory and regulatory requirements. See "Part I, Item 1. Regulatory Environment" in our <u>[2022 Annual Report on Form 10-K](http://www.sec.gov/Archives/edgar/data/1261654/000126165421000073/uti-20210930.htm)</u>.

***State Authorization***

To operate and offer postsecondary programs, and to be certified to participate in Title IV Programs, each of our institutions must obtain and maintain authorization from the state in which it is physically located (its "Home State"). To engage in recruiting or educational activities outside of its Home State, each institution also may be required to obtain and maintain authorization from the states in which it is recruiting or engaging in educational activities. The level of regulatory oversight varies substantially from state to state and is extensive in some states. State laws may establish standards for instruction, qualifications of faculty, location and nature of facilities and equipment, administrative procedures, marketing, recruiting, student outcomes reporting, disclosure obligations to students, limitations on mandatory arbitration clauses in enrollment agreements, financial operations, and other operational matters. Some states prescribe standards of financial responsibility and mandate that institutions post surety bonds. Many states have requirements for institutions to disclose institutional data to current and prospective students, as well as to the public. And some states require that our schools meet prescribed performance standards as a condition of continued approval. States can and often do revisit, revise, and expand their regulations governing postsecondary education and recruiting.

------

<u>[**Table of Contents**](#i3fd8c9cc921945018616af2cd8eacdac_7)</u>

**UNIVERSAL TECHNICAL INSTITUTE, INC. AND SUBSIDIARIES**

**NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS**

(In thousands, except per share amounts)

(Unaudited)

All UTI institutions and the Concorde Career Colleges, Kansas City institution are authorized to participate in the State Authorization Reciprocity Agreement ("SARA"). SARA is an agreement among member states, districts and territories that establishes comparable national standards for interstate offering of post-secondary distance education courses and programs. SARA is overseen by a national council and administered by four regional education compacts. As of July 1, 2022, 49 states (all but California), the District of Columbia, Puerto Rico and the U.S. Virgin Islands have joined SARA. Each of our institutions holds either the state or SARA authorizations required to operate and offer postsecondary education programs, and to recruit in the states in which it engages in recruiting activities.

***State Licensing Boards***

Many educational programs leading to professional licensure in a regulated profession require approval from, and are subject to, ongoing oversight by state agencies or boards. Certain Concorde healthcare programs, such as the Vocational Nursing, Practical Nursing, Dental Assistant, Massage Therapy, Nursing Practice (RN) programs, require and have obtained state licensure. Such programs are required to meet the standards of the state licensure agency or board and must periodically renew their licenses by completing a comprehensive license renewal process.

***Institutional Accreditation***

Accreditation is a non-governmental process through which an institution voluntarily submits to ongoing qualitative reviews by an organization of peer institutions. Institutional accreditation by an ED-recognized accreditor is required for an institution to be certified to participate in Title IV Programs. All of the UTI institutions and 14 of the Concorde institutions are accredited by the Accrediting Commission of Career Schools and Colleges ("ACCSC"). The remaining two Concorde institutions are accredited by the Council on Occupational Education ("COE"). Both ACCSC and COE are accrediting agencies recognized by ED. ACCSC and COE review the academic quality of each institution's instructional programs, as well as the administrative and financial operations of the institution to ensure that it has the resources necessary to perform its educational mission, implement continuous improvement processes, and support student success. Our institutions must submit annual reports, and at times, supplemental reports, to demonstrate ongoing compliance and improvement. ACCSC and COE require institutions to disclose certain institutional information to current and prospective students, as well as to the public, and require that our schools and programs meet various performance standards as a condition of continued accreditation. Institutions must periodically renew their accreditation by completing a comprehensive renewal of accreditation process. See "Part I, Item 1. Regulatory Environment - Accreditation" in our <u>[2022 Annual Report on Form 10-K](http://www.sec.gov/Archives/edgar/data/1261654/000126165421000073/uti-20210930.htm)</u> for further details and the current status of UTI campus' accreditation.

***Programmatic Accreditation***

In addition to institutional accreditation, programmatic accreditation may be required for particular educational programs. Programmatic accreditors review specialized and professional programs in a range of fields and disciplines within an institution to ensure the public that an academic program has undergone a rigorous review process and found to meet high standards for educational quality. Certain Concorde healthcare programs, including the Physical Therapist Assistant, Dental Hygiene, Neurodiagnostic Technology, Polysomnographic Technology, Respiratory Therapy, Surgical Technology, Radiologic Technology, Diagnostic Medical Sonography, Cardiovascular Sonography, Occupational Therapy Assistant, Pharmacy Technician, and Occupational Therapy Assistant programs, have obtained programmatic accreditation. Such programs are required to meet the standards of their programmatic accreditor and must periodically renew their accreditation by completing a comprehensive accreditation renewal process.

***Title IV Programs***

The federal government provides a substantial part of its support for postsecondary education through Title IV Programs in the form of grants and loans to students who can use those funds at any institution that has been certified as eligible to participate by ED. All of our institutions are certified to participate in Title IV Programs. Significant factors relating to Title IV Programs that could adversely affect us include:

• *The 90/10 Rule*.** As a condition of participation in Title IV Programs, proprietary institutions must agree when they sign their PPA to comply with the "90/10 rule." Under the current 90/10 rule, to remain eligible to participate in the federal

------

<u>[**Table of Contents**](#i3fd8c9cc921945018616af2cd8eacdac_7)</u>

**UNIVERSAL TECHNICAL INSTITUTE, INC. AND SUBSIDIARIES**

**NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS**

(In thousands, except per share amounts)

(Unaudited)

student aid programs, a proprietary institution must derive at least 10% of its revenues for each fiscal year from sources other than "Federal education assistance funds." Federal education assistance funds are defined as "federal funds that are disbursed or delivered to or on behalf of a student to be used to attend such institution." ED published a proposed 90/10 rule on July 28, 2022 and a final rule on October 28, 2022. The new rule will take effect July 1, 2023 and will apply to any annual audit submission for a proprietary institutional fiscal year beginning on or after January 1, 2023.

• *Administrative Capability.* To continue its participation in Title IV Programs, an institution must demonstrate that it remains administratively capable of providing the education it promises and of properly managing the Title IV Programs. ED assesses the administrative capability of each institution that participates in Title IV Programs under a series of standards listed in the regulations, which cover a wide range of operational and administrative topics, including the designation of capable and qualified individuals, the quality and scope of written procedures, the adequacy of institutional communication and processes, the timely resolution of issues, the sufficiency of recordkeeping, and the frequency of findings of noncompliance, to name a few. ED's administrative capability standards also include thresholds and expectations for federal student loan cohort default rates (discussed below), satisfactory academic progress, and loan counseling. Failure to satisfy any of the standards may lead ED to find the institution ineligible to participate in Title IV Programs, require the institution to repay Title IV Program funds, change the method of payment of Title IV Program funds, place the institution on provisional certification as a condition of its continued participation or take other actions against the institution.

• *Three-Year Student Loan Default Rates.* To remain eligible to participate in Title IV Programs, institutions also must maintain federal student loan cohort default rates below specified levels. An institution whose three-year cohort default rate is 15% or greater for any one of the three preceding years is subject to a 30-day delay in receiving the first disbursement on federal student loans for first-time borrowers. An institution whose cohort default rate exceeds 30% in consecutive fiscal years may be subject to conditions and restrictions, and will lose eligibility if the rate remains above 30% three years in a row. An institution also will lose eligibility if its rate exceeds 40% for any fiscal year.

• *Financial Responsibility.* All institutions participating in Title IV Programs also must satisfy specific ED standards of financial responsibility. Among other things, an institution must meet all of its financial obligations, including required refunds to students and any Title IV Program liabilities and debts, be current in its debt payments, comply with certain past performance requirements, and not receive any adverse, qualified, or disclaimed opinion by its accountants in its audited financial statements. Each year, ED also evaluates institutions' financial responsibility by calculating a "composite score," which utilizes information provided in the institutions' annual audited financial statements. The composite score is based on three ratios: (1) the equity ratio which measures the institution's capital resources, ability to borrow and financial viability; (2) the primary reserve ratio which measures the institution's ability to support current operations from expendable resources; and (3) the net income ratio which measures the institution's ability to operate at a profit. Between composite score calculations, ED also will reevaluate the financial responsibility of an institution following the occurrence of certain "triggering events," which must be timely reported to the agency.

• *Title IV Program Rulemaking.* ED is almost continuously engaged in one or more negotiated rulemakings, which is the process pursuant to which it revisits, revises, and expands the complex and voluminous Title IV Program regulations. ED is currently managing two significant rulemaking efforts. First, between October and December 2021, ED held three rounds of negotiations as part of the Affordability and Student Loans rulemaking. The negotiators considered nine issue areas, including the borrower defense to repayment rule, closed school loan discharges and loan repayment plans. Second, between January and March of 2022, ED held three rounds of negotiations as part of the Institutional and Programmatic Eligibility rulemaking. The negotiators considered seven issue areas, including administrative capability, financial responsibility, gainful employment, change of ownership and control, ability to benefit and the 90/10 rule. On October 28, 2022, ED published a final rule amending regulations governing Pell Grants for prison education programs, the 90/10 rule, and changes in ownership and control, effective July 1, 2023. On November 1, 2022, ED published a final rule governing borrower defense to repayment rule, closed school loan discharges, pre-dispute arbitration and class action waiver clauses, interest capitalization on Federal student loans, Public Student Loan Forgiveness, total and permanent disability discharges, and false certification discharges, also effective July 1, 2023. The regulated community is awaiting proposed rules on the remaining topics covered by ED's current negotiated rulemakings. ED also has announced a slate of new negotiated rulemakings to begin in Spring 2023, which will address state authorization, accreditation, distance education, and other topics. We devote significant effort to understanding the effects of ED

------

<u>[**Table of Contents**](#i3fd8c9cc921945018616af2cd8eacdac_7)</u>

**UNIVERSAL TECHNICAL INSTITUTE, INC. AND SUBSIDIARIES**

**NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS**

(In thousands, except per share amounts)

(Unaudited)

regulations and rulemakings on our business and to developing compliant solutions that also are congruent with our business, culture, and mission to serve our students and industry relationships.

• *Non-Discrimination Rulemakings.* On July 12, 2022, ED published a proposed rule to amend the regulations implementing Title IX of the Education Amendments of 1972 ("Title IX"). The regulated community is awaiting a final Title IX rule. ED also has indicated that it will be proposing a rule to amend regulations related to nondiscrimination on the basis of disability in the Spring of 2023.

***Department of Veterans Affairs Benefit Programs***

Some of our students also receive financial aid from federal sources other than Title IV Programs, such as the programs administered by the Department of Veterans Affairs ("VA"), the Department of Defense ("DOD") and under the Workforce Innovation and Opportunity Act.

In 2022, the UTI programs derived approximately 13% of their revenues, on a cash basis, from veterans' benefits programs, which include the Post-9/11 GI Bill, the Montgomery GI Bill, the Reserve Education Assistance Program ("REAP") and VA Vocational Rehabilitation. To continue participation in veterans' benefits programs, an institution must comply with certain requirements established by the VA.

***Other Federal and State Student Aid Programs***

The Department of Veterans Affairs, the Department of Defense, the Department of Labor, the Department of Education (through non-Title IV programs), and certain states provide support to postsecondary students through grants, benefits, loans, or scholarships. All of our institutions that engage in such programs must comply with the eligibility and participation requirements applicable to each of these funding programs, which vary by funding agency and program.

Each year we derive a portion of our revenues, on a cash basis, from veterans' benefits programs, which include the Post-9/11 GI Bill, the Montgomery GI Bill, the Reserve Education Assistance Program ("REAP") and VA Vocational Rehabilitation. To continue participation in veterans' benefits programs, an institution must comply with certain requirements established by the VA.

Additionally, some states provide financial aid to our students in the form of grants, loans, or scholarships. The UTI campuses in Long Beach, Rancho Cucamonga and Sacramento, California, as well as the Concorde campuses in Garden Grove, North Hollywood and San Diego, California for example, are currently eligible to participate in the Cal Grant program. All of our institutions must comply with the eligibility and participation requirements applicable to each of these funding programs, which vary by funding agency and program.

***Consumer Protections Laws and Regulations***

As a postsecondary educational institution, we are subject to a broad range of consumer protection and other laws, such as recruiting, marketing, the protection of personal information, student financing and payment servicing, enforced by federal agencies such as the FTC and CFPB and various state agencies and state attorneys general. We devote significant effort to complying with state and federal consumer protection laws.

We received a January 18, 2022 letter from the Consumer Financial Protection Bureau ("CFPB") explaining that it was assessing whether UTI "is subject to the CFPB's supervisory authority based on its activities related to student lending." The CFPB's letter then requested certain information about extensions of credit to UTI students; generally explained the source and scope of the CFPB's regulatory authority; and advised that, after it reviewed the requested materials, the CFPB "anticipates providing guidance regarding whether UTI is subject to CFPB's supervisory authority." We have provided the requested information and are awaiting further guidance, if any, from the CFPB.

Both UTI and Concorde, along with 68 other proprietary institutions, received an October 6, 2021 letter from the FTC providing notice that engaging in deceptive or unfair conduct in the education marketplace violates consumer protection laws

------

<u>[**Table of Contents**](#i3fd8c9cc921945018616af2cd8eacdac_7)</u>

**UNIVERSAL TECHNICAL INSTITUTE, INC. AND SUBSIDIARIES**

**NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS**

(In thousands, except per share amounts)

(Unaudited)

and could lead to significant civil penalties. The notice stated that an institutions receipt of the letter "does not reflect any assessment as to whether they have engaged in deceptive or unfair conduct," and the FTC did not request any information.

***The CARES Act, the CRRSAA, and ARPA***

During fiscal 2020 and 2021 various pieces of legislation were issued related to the COVID-19 pandemic including the Coronavirus Aid, Relief, and Economic Security Act, the Coronavirus Response and Relief Supplemental Appropriations Act, 2021 and the American Rescue Plan Act. This legislation, along with guidance from the ED, are discussed at length in "Note 24 - Governmental Regulation and Financial Aid" in our <u>[2022 Annual Report on Form 10-K](http://www.sec.gov/Archives/edgar/data/1261654/000126165421000073/uti-20210930.htm)</u>. For additional information and risks associated with this legislation, see Item 1A. "Risk Factors" in our <u>[2022 Annual Report on Form 10-K](http://www.sec.gov/Archives/edgar/data/1261654/000126165421000073/uti-20210930.htm)</u>.

***Distance Education***

Institutions that offer instruction outside of their Home State must comply with federal regulations governing state authorization for distance education in order to participate in the Title IV student financial aid programs. We continue to work to ensure that our programming complies with applicable distance education rules and standards, including ED's new distance education rules, which became effective July 1, 2021. We also will closely monitor any new rulemaking initiated in Spring 2023 that concerns state authorization or distance education.

In response to the COVID-19 pandemic, ED provided broad approval for institutions to use distance education without going through the standard ED approval process. ED also permitted accreditors to waive their distance education review requirements. ED's temporary flexibilities currently remain in place, and will continue through the end of the payment period that begins after the date on which the federally-declared national emergency related to COVID-19 is rescinded.

To date, we have received approval from ACCSC and COE to permanently offer blended format programs that utilize both distance and on-ground education. Additionally, we have received permanent approvals by all state education authorizing agencies to offer blended format programs.

------

<u>[**Table of Contents**](#i3fd8c9cc921945018616af2cd8eacdac_7)</u> 

**Item 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS** 

*The following discussion and analysis should be read in conjunction with the condensed consolidated financial statements and related notes included in this Quarterly Report on Form 10-Q and those in our <u>[202](https://www.sec.gov/ix?doc=/Archives/edgar/data/1261654/000126165422000105/uti-20220930.htm)[2](https://www.sec.gov/ix?doc=/Archives/edgar/data/1261654/000126165422000105/uti-20220930.htm)[Annual Report on Form 10-K](https://www.sec.gov/ix?doc=/Archives/edgar/data/1261654/000126165422000105/uti-20220930.htm)</u>. This discussion contains forward-looking statements that involve risks and uncertainties. Our actual results may differ materially from those anticipated in such forward-looking statements as a result of certain factors, including but not limited to those described under "Risk Factors" in our <u>[202](https://www.sec.gov/ix?doc=/Archives/edgar/data/1261654/000126165422000105/uti-20220930.htm)[2](https://www.sec.gov/ix?doc=/Archives/edgar/data/1261654/000126165422000105/uti-20220930.htm)[Annual Report on Form 10-K](https://www.sec.gov/ix?doc=/Archives/edgar/data/1261654/000126165422000105/uti-20220930.htm)</u> and included in Part II, Item 1A of this Quarterly Report on Form 10-Q. See also "Cautionary Note Regarding Forward-Looking Statements" on page ii of this Quarterly Report on Form 10-Q.*

**Company Overview**

Universal Technical Institute, Inc., which together with its subsidiaries is referred to as the "Company", "we," "us" or "our," was founded in 1965 and is a leading workforce solutions provider of transportation, skilled trades and healthcare education programs, whose mission is to serve students, partners, and communities by providing quality education and support services for in-demand careers across a number of highly-skilled fields. We offer the majority of our programs in a blended learning model that combines instructor-facilitated online teaching and demonstrations with hands-on labs. As a result of the Concorde Career Colleges acquisition on December 1, 2022, beginning with this reporting period we have two reportable segments as follows:

***Universal Technical Institute ("UTI"):*** UTI operates 16 campuses located in nine states and offers a wide range of degree and non-degree transportation and skilled trades technical training programs under brands such as Universal Technical Institute, Motorcycle Mechanics Institute and Marine Mechanics Institute (collectively "MMI"), NASCAR Technical Institute, and MIAT College of Technology ("MIAT"). UTI also offers manufacturer specific advanced training programs, which include student-paid electives, at our campuses and manufacturer or dealer sponsored training at certain campuses and dedicated training centers. Lastly, UTI provides dealer technician training or instructor staffing services to manufacturers. UTI works closely with over 35 original equipment manufacturers and industry brand partners to understand their needs for qualified service professionals.

**Concorde Career Colleges ("Concorde"):** Concorde operates across 17 campuses in eight states, offering degree, non-degree, and continuing education programs in the allied health, dental, nursing, patient care and diagnostic fields. Concorde believes in preparing students for their health care careers with practical, hands-on experiences including opportunities to learn while providing care to real patients. Prior to graduation, students will complete a number of hours in a clinical setting or externship, depending upon their program of study. We acquired Concorde on December 1, 2022. See Note 4 on "Acquisitions" for additional information.

"Corporate" includes corporate related expenses that are not allocated to the UTI or Concorde reportable segments. These costs were previously allocated across our former "Postsecondary Education" reportable segment and "Other" category based upon compensation expense. Additional information about our reportable segments is presented in Note 19.

All of our campuses are accredited and are eligible for federal student financial assistance funds under the Higher Education Act of 1965, as amended ("HEA"), commonly referred to as Title IV Programs, which are administered by the U.S. Department of Education ("ED"). Our programs are also eligible for financial aid from federal sources other than Title IV Programs, such as the programs administered by the U.S. Department of Veterans Affairs ("VA") and under the Workforce Innovation and Opportunity Act.

We believe that our industry-focused educational model and national presence has enabled us to develop valuable industry relationships, which provide us with significant competitive advantages and supports our market leadership, along with enabling us to provide highly specialized education to our students, resulting in enhanced employment opportunities and the potential for higher wages for our graduates.

**Concord Career Colleges Acquisition**

On December 1, 2022, we completed the acquisition contemplated by the previously announced Stock Purchase Agreement (the "Purchase Agreement"), dated May 3, 2022, by and among the Company, Concorde Career Colleges, Inc., a Delaware corporation ("Concorde"); Liberty Partners Holdings 28, L.L.C., a Delaware limited liability company, and Liberty

------

<u>[**Table of Contents**](#i3fd8c9cc921945018616af2cd8eacdac_7)</u> 

Investment IIC, LLC, a Delaware limited liability company (each a "Seller," and collectively, the "Sellers"); and Liberty Partners L.P., a Delaware limited partnership, in its capacity as a representative of the Sellers. Under the terms of the Purchase Agreement, we acquired of all of the issued and outstanding shares of capital stock of Concorde for a base purchase price of $50.0 million, less $1.3 million in net adjustments, for total cash consideration paid of $48.7 million. The final cash consideration paid is subject to closing working capital and other customary adjustments. See the "Liquidity and Capital Resources" section of this MD&A for a discussion on the financing used to fund the acquisition. The risks and uncertainties related to the acquisition are described in Item 1A. "Risk Factors" of our <u>[2022 Annual Report on Form 10-K](https://www.sec.gov/ix?doc=/Archives/edgar/data/1261654/000126165422000105/uti-20220930.htm)</u> for the fiscal year ended September 30, 2022.

**Overview of the Three Months Ended December 31, 2022**

***Student Metrics***

---

| | | | |
|:---|:---|:---|:---|
| | **Three Months Ended December 31, 2022** | **Three Months Ended December 31, 2022** | **Three Months Ended December 31, 2022** |
| | **UTI** | **Concorde** | **Consolidated** |
| Total new student starts | 1974 | 336 | 2310 |
| Average undergraduate full-time active students | 13511 | 7737 | 21248 |
| End of period undergraduate full-time active students | 12657 | 7630 | 20287 |

---

---

| | | | |
|:---|:---|:---|:---|
| | **Three Months Ended December 31, 2021** | **Three Months Ended December 31, 2021** | **Three Months Ended December 31, 2021** |
| | **UTI** | **Concorde** | **Consolidated** |
| Total new student starts | 1972 |  | 1972 |
| Average undergraduate full-time active students | 13729 |  | 13729 |
| End of period undergraduate full-time active students | 13129 |  | 13129 |

---

---

| | | | |
|:---|:---|:---|:---|
| | **% Change** | **% Change** | **% Change** |
| | **UTI** | **Concorde** | **Consolidated** |
| Total new student starts | 0.1% | 100.0% | 17.1% |
| Average undergraduate full-time active students | (1.6)% | 100.0% | 54.8% |
| End of period undergraduate full-time active students | (3.6)% | 100.0% | 54.5% |

---

The decrease in the UTI average undergraduate full-time active students and end of period undergraduate full-time active students was due to lower growth in student starts in the prior fiscal year. On a consolidated basis, the acquisition of Concorde increases our new student starts, average and end of period undergraduate full-time active students.

Our ability to start new students can be influenced by various factors including: ongoing impacts of the COVID-19 pandemic and related variants, unemployment rates; competition; adverse media coverage, legislative hearings, regulatory actions and investigations by attorneys general and various agencies related to allegations of wrongdoing on the part of other companies within the education and training services industry, which can cast the aggregate "for-profit" education industry in a negative light; and the state of the general macro-economic environment and its impact on price sensitivity and the ability and willingness of students and their families to incur debt to fund their education.

***Operations*** 

Revenues for the three months ended December 31, 2022 were $120.0 million, an increase of $14.9 million, or 14.2%, from the comparable period in the prior year. The acquisition of Concorde contributed $14.4 million of revenue. Excluding the acquisition, our revenues increased slightly.

We had income from operations of $4.4 million during the three months ended December 31, 2022, compared to income from operations of $13.6 million during the three months ended December 31, 2021. The decrease in our income from operations was primarily driven by increased costs associated with our new campus and program rollouts in the prior fiscal year, and both ongoing and one-time costs associated with our growth and diversification strategy. Additionally, productivity improvements and proactive cost actions have been a key part of our operating model for the past several years, and we continue to identify and execute on efficiency opportunities throughout our cost structure, while improving and investing in the overall student experience.

------

<u>[**Table of Contents**](#i3fd8c9cc921945018616af2cd8eacdac_7)</u> 

***Business Strategy***

Our core business strategies are aligned with our mission to serve students, partners and communities by providing quality education and training for in-demand careers. Additionally, as we evolve our business model, we are focused on growth and diversification which is achieved through acquisitions, opening new campus locations, the expansion of new program offerings, and new funding and business operating models.

During the three months ended December 31, 2022, we executed the following as part of our growth and diversification strategy:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• As previously noted, we closed on the acquisition of Concorde on December 1, 2022. Concorde is a leading provider of industry-aligned healthcare education programs in fields such as nursing, dental hygiene and medical diagnostics. Concorde currently operates 17 campuses across eight states with approximately 7,600 students, and offers its programs in ground, hybrid and online formats. The acquisition aligns with our growth and diversification strategy, which is focused on offering a broader array of high-quality, in-demand workforce education solutions which both prepare students for a variety of careers in fast-growing fields and help close the country's skills gap by leveraging key industry partnerships.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• UTI expanded the Volvo TEKNIKER Apprentice Program, a 12-week, manufacturer-paid apprentice program to Volvo's training facility in Ridgeville, South Carolina. Previously this program was only offered at UTI's Avondale, Arizona campus. These are the only two locations in the country offering the program.

In addition, we continue to pursue other opportunities that align with our growth and diversification strategy.

***Regulatory Environment***

See Note 20 of the notes to our condensed consolidated financial statements herein for a discussion of our regulatory environment.

**Results of Operations: Three Months Ended December 31, 2022 Compared to Three Months Ended December 31, 2021** 

The following table sets forth selected statements of operations data as a percentage of revenues for each of the periods indicated.

---

| | | |
|:---|:---|:---|
| | **Three Months Ended December 31,** | **Three Months Ended December 31,** |
| | **2022** | **2021** |
| Revenues | 100.0% | 100.0% |
| Operating expenses: |  |  |
| &nbsp;&nbsp;&nbsp;Educational services and facilities | 51.2% | 45.6% |
| &nbsp;&nbsp;&nbsp;Selling, general and administrative | 45.1% | 41.5% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total operating expenses | 96.3% | 87.1% |
| Income from operations | 3.7% | 12.9% |
| &nbsp;&nbsp;&nbsp;Interest income | 0.7% | —% |
| &nbsp;&nbsp;&nbsp;Interest expense | (1.2)% | (0.2)% |
| &nbsp;&nbsp;&nbsp;Other income, net | 0.3% | 0.1% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total other expense, net | (0.2)% | (0.1)% |
| Income before income taxes | 3.5% | 12.8% |
| Income tax (expense) benefit | (1.3)% | 1.3% |
| Net income | 2.2% | 14.1% |
| Preferred stock dividends | (1.1)% | (1.3)% |
| Income available for distribution | 1.1% | 12.8% |
| Income allocated to participating securities | (0.4)% | (5.0)% |
| Net income available to common shareholders | 0.7% | 7.8% |

---

------

<u>[**Table of Contents**](#i3fd8c9cc921945018616af2cd8eacdac_7)</u> 

***Revenues***

The following table presents revenue by segment (in thousands):

---

| | | | |
|:---|:---|:---|:---|
| | **Three Months Ended December 31, 2022** | **Three Months Ended December 31, 2022** | **Three Months Ended December 31, 2022** |
| | **UTI** | **Concorde** | **Consolidated** |
| Revenue | $105573 | $14431 | $120004 |
|  | **Three Months Ended December 31, 2021** | **Three Months Ended December 31, 2021** | **Three Months Ended December 31, 2021** |
|  | **UTI** | **Concorde** | **Consolidated** |
| Revenue | $105075 | $— | $105075 |
| % Change | 0.5% | 100.0% | 14.2% |

---

Revenues for the three months ended December 31, 2022 were $120.0 million, an increase of $14.9 million, or 14.2%, as compared to revenues of $105.1 million for the three months ended December 31, 2021.

*UTI*

Revenues for UTI for the three months ended December 31, 2022 were $105.6 million. UTI had a 1.6% decrease in average undergraduate full-time active students due to lower student starts in fiscal 2022. Revenue increased slightly despite the slight decline in the average undergraduate full-time students as it was offset by an increase in the average revenue per student as compared to the prior year. UTI recognized $2.0 million and $2.5 million on an accrual basis related to revenues and interest under our proprietary loan program for the three months ended December 31, 2022, and 2021, respectively.

*Concorde*

Revenues for Concorde, which represent one month as Concorde was acquired on December 1, 2022, were $14.4 million. Note that due to phasing and seasonality of clinical programs, December is one of Concorde's lowest revenue months during the fiscal year.

***Educational services and facilities expenses***

Educational services and facilities expenses were $61.4 million for the three months ended December 31, 2022, which represents an increase of $13.5 million as compared to $47.9 million for the three months ended December 31, 2021, which is primarily due to the acquisition of Concorde on December 1, 2022.

The following table sets forth the significant components of our educational services and facilities expenses by segment (in thousands):

---

| | | | |
|:---|:---|:---|:---|
| | **Three Months Ended December 31, 2022** | **Three Months Ended December 31, 2022** | **Three Months Ended December 31, 2022** |
| | **UTI** | **Concorde** | **Consolidated** |
| Salaries, employee benefits and tax expense | $26852 | $6559 | $33411 |
| Bonus expense | 656 |  | 656 |
| Stock-based compensation | 81 |  | 81 |
| &nbsp;&nbsp;&nbsp;Compensation and related costs | 27589 | 6559 | 34148 |
| Occupancy costs | 7682 | 1764 | 9446 |
| Depreciation and amortization expense | 4417 | 420 | 4837 |
| Supplies, maintenance and student expense | 4585 | 911 | 5496 |
| Contract services expense | 1065 | 56 | 1121 |
| Other educational services and facilities expense | 5539 | 821 | 6360 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total educational services and facilities expense | $50877 | $10531 | $61408 |

---

------

<u>[**Table of Contents**](#i3fd8c9cc921945018616af2cd8eacdac_7)</u> 

---

| | | | |
|:---|:---|:---|:---|
| | **Three Months Ended December 31, 2021** | **Three Months Ended December 31, 2021** | **Three Months Ended December 31, 2021** |
| | **UTI** | **Concorde** | **Consolidated** |
| Salaries, employee benefits and tax expense | $24282 | $— | $24282 |
| Bonus expense | 539 |  | 539 |
| Stock-based compensation | 46 |  | 46 |
| &nbsp;&nbsp;&nbsp;Compensation and related costs | 24867 |  | 24867 |
| Occupancy costs | 8996 |  | 8996 |
| Depreciation and amortization expense | 3407 |  | 3407 |
| Supplies, maintenance and student expense | 4528 |  | 4528 |
| Contract services expense | 1248 |  | 1248 |
| Other educational services and facilities expense | 4855 |  | 4855 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total educational services and facilities expense | $47901 | $— | $47901 |

---

*UTI*

Compensation and related costs increased by $2.7 million for the three months ended December 31, 2022 primarily due to increased instructor salaries related to the opening of two new campuses and program expansions since the prior year.

Occupancy costs decreased by $1.3 million for the three months ended December 31, 2022. The decrease was primarily due to the purchasing of our Lisle, Illinois campus and the consolidation of the MMI and UTI campuses in both Arizona and Florida into single sites. The decrease was partially offset by the opening of the Miramar, Florida campus.

Depreciation expense increased by $1.0 million for the three months ended December 31, 2022 primarily due to purchasing the Lisle Campus and the capital expenditures related to construction and new equipment costs for the new campuses in Austin, Texas and Miramar, Florida and the new welding programs in Mooresville, North Carolina and Exton, Pennsylvania, all of which opened last year.

Other educational services and facilities expense increased by $0.7 million for the three months ended December 31, 2022. The increase was primarily due to the cost of welding gear of $0.3 million due to the expansion of our welding programs to our Mooresville, North Carolina and Exton, Pennsylvania campuses, a $0.3 million increase in expense related to training aids, and an increase in the cost of tools of $0.3 million.

*Concorde*

Educational services and facilities expenses for Concorde, which represent one month as Concorde was acquired on December 1, 2022, were $10.5 million.

***Selling, general and administrative expenses***

Selling, general and administrative expenses for the three months ended December 31, 2022 were $54.1 million. This represents an increase of $10.6 million, as compared to $43.6 million for the three months ended December 31, 2021, which is primarily due to the acquisition of Concorde on December 1, 2022 and both ongoing and one-time costs associated with our growth and diversification strategy.

------

<u>[**Table of Contents**](#i3fd8c9cc921945018616af2cd8eacdac_7)</u> 

The following table sets forth the significant components of our selling, general and administrative expenses by segment (in thousands):

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended December 31, 2022** | **Three Months Ended December 31, 2022** | **Three Months Ended December 31, 2022** | **Three Months Ended December 31, 2022** |
| | **UTI** | **Concorde** | **Corporate** | **Consolidated** |
| Salaries, employee benefits and tax expense | $15404 | $1917 | $5101 | $22422 |
| Bonus expense | 2887 | 188 | 1134 | 4209 |
| Stock-based compensation | 171 |  | 917 | 1088 |
| &nbsp;&nbsp;&nbsp;Compensation and related costs | 18462 | 2105 | 7152 | 27719 |
| Advertising and marketing expense | 13349 | 1280 |  | 14629 |
| Professional and contract services expense | 2000 | 41 | 2175 | 4216 |
| Other selling, general and administrative expenses | 4370 | 1200 | 2014 | 7584 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total selling, general and administrative expenses | $38181 | $4626 | $11341 | $54148 |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended December 31, 2021** | **Three Months Ended December 31, 2021** | **Three Months Ended December 31, 2021** | **Three Months Ended December 31, 2021** |
| | **UTI** | **Concorde** | **Corporate** | **Consolidated** |
| Salaries, employee benefits and tax expense | $13637 | $— | $4889 | $18526 |
| Bonus expense | 2968 |  | 986 | 3954 |
| Stock-based compensation | 123 |  | 537 | 660 |
| &nbsp;&nbsp;&nbsp;Compensation and related costs | 16728 |  | 6412 | 23140 |
| Advertising and marketing expense | 11959 |  |  | 11959 |
| Professional and contract services expense | 736 |  | 2082 | 2818 |
| Other selling, general and administrative expenses | 4584 |  | 1095 | 5679 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total selling, general and administrative expenses | $34007 | $— | $9589 | $43596 |

---

*UTI*

Compensation and related costs increased by $1.7 million for the three months ended December 31, 2022 primarily due to an increase in headcount to support growth and diversification initiatives as compared to the prior year.

Advertising and marketing expense increased by $1.4 million for the three months ended December 31, 2022, primarily due to timing of spend along with incremental investment to support growth objectives. We continue to target cost-efficient marketing with an increased focus on digital media. Advertising and marketing expense as a percentage of revenues increased to 12.2% for the three months ended December 31, 2022 as compared to 11.4% in the prior year.

Professional and contract services expense increased by $1.3 million primarily due to one-time costs incurred related to growth and diversification initiatives, primarily integration costs.

------

<u>[**Table of Contents**](#i3fd8c9cc921945018616af2cd8eacdac_7)</u> 

*Concorde*

Selling, General and Administrative expenses for Concorde, which represented one month as Concorde was acquired on December 1, 2022, were $4.6 million.

*Corporate*

Selling, General and Administrative expenses for Corporate increased by $1.8 million for the three months ended December 31, 2022. This was primarily due to compensation and related costs which increased by $0.7 million due to an increase in headcount to support growth and diversification initiatives as compared to the prior year.

***Income taxes***

Income tax expense for the three months ended December 31, 2022 was $1.5 million, or 36.5% of pre-tax income, compared to an income tax benefit of $1.3 million, or (10.0)% of pre-tax income, for the three months ended December 31, 2021. The income tax expense for the three months ended December 31, 2022 is primarily driven by non-deductible executive compensation, transaction costs and state and local income and franchise taxes. The income tax benefit recorded during the three months ended December 31, 2021 is primarily comprised of the valuation allowance impact related to the MIAT deferred tax liability for indefinite lived intangibles which are available to offset a portion of our indefinite lived deferred tax assets, offset by current state tax expense. See Note 15 of the notes to the condensed consolidated financial statements herein for additional details.

***Preferred stock dividends***

As of December 31, 2022 and 2021, 675,885 and 700,000 shares of Series A Convertible Preferred Stock were issued and outstanding, respectively. Pursuant to the Certificate of Designations of the Series A Preferred Stock, we recorded a preferred stock cash dividend of $1.3 million for the three months ended December 31, 2022 and 2021, respectively.

***Income available for distribution***

Income available for distribution refers to net income reduced by dividends on our Series A Preferred Stock. As a result of the foregoing, we reported income available for distribution of $1.4 million and $13.5 million for the three months ended December 31, 2022 and 2021, respectively.

***Income allocated to participating securities***

Series A Preferred Stock is considered a participating security because, in the event that we pay a dividend or make a distribution on the outstanding common stock, we shall also pay each holder of the Series A Preferred Stock a dividend on an as-converted basis. The two-class method is an earnings allocation formula that determines earnings per share for common stock and participating securities according to dividend and participation rights in undistributed earnings. Under this method, all earnings, distributed and undistributed, are allocated to common shares and participating securities based on their respective rights to receive dividends. The amount of income allocated to the participating securities for the three months ended December 31, 2022 and 2021 was $0.5 million and $5.3 million, respectively.

***Net income available to common shareholders***

After allocating the income to the participating securities, we had $0.9 million and $8.2 million of net income available to

common shareholders for the three months ended December 31, 2022 and 2021, respectively.

**Non-GAAP Financial Measures**

Our earnings before interest income, income taxes, depreciation and amortization ("EBITDA") for the three months ended December 31, 2022 and 2021 were $10.0 million and $17.4 million, respectively. We define EBITDA as net income, before interest (income) expense, income tax expense (benefit), and depreciation and amortization.

------

<u>[**Table of Contents**](#i3fd8c9cc921945018616af2cd8eacdac_7)</u> 

EBITDA is a non-GAAP financial measure which is provided to supplement, but not substitute for, the most directly comparable GAAP measure. We choose to disclose this non-GAAP financial measure because it provides an additional analytical tool to clarify our results from operations and helps to identify underlying trends. Additionally, this measure helps compare our performance on a consistent basis across time periods. Management also utilizes EBITDA as a performance measure internally. To obtain a complete understanding of our performance, this measure should be examined in connection with net income determined in accordance with GAAP. Since the items excluded from this measure should be examined in connection with net income in determining financial performance under GAAP, this measure should not be considered an alternative to net income as a measure of our operating performance or profitability. Exclusion of items in our non-GAAP presentation should not be construed as an inference that these items are unusual, infrequent or non-recurring. Other companies, including other companies in the education industry, may calculate EBITDA differently than we do, limiting its usefulness as a comparative measure across companies. Investors are encouraged to use GAAP measures when evaluating our financial performance.

EBITDA reconciles to net income, as follows (in thousands):

---

| | | |
|:---|:---|:---|
| | **Three Months Ended December 31,** | **Three Months Ended December 31,** |
| | **2022** | **2021** |
| Net income | $2648 | $14822 |
| Interest income | (823) | (12) |
| Interest expense | 1423 | 233 |
| Income tax expense (benefit) | 1525 | (1347) |
| Depreciation and amortization<sup>(1)</sup> | 5248 | 3679 |
| &nbsp;&nbsp;&nbsp;&nbsp;EBITDA | $10021 | $17375 |

---

(1) Includes depreciation of training equipment obtained in exchange for services of $0.2 million for the three months ended December 31, 2022 and 2021, respectively.

**Liquidity and Capital Resources** 

***Overview of Liquidity***

Based on past performance and current expectations, we believe that our cash flows from operations, cash on hand and investments will satisfy our working capital needs, capital expenditures, commitments and other liquidity requirements associated with our existing operations, as well as announced growth and diversification initiatives over the next 12 months and beyond. Our cash position is available to fund strategic long-term growth initiatives, including opening additional campuses in new markets and the creation of new programs, such as welding, in existing markets where we continue to optimize utilization of our campus facilities.

Our aggregate cash and cash equivalents were $162.2 million as of December 31, 2022, an increase of $95.8 million from September 30, 2022.

*Strategic Uses of Cash*

On December 1, 2022, using funds from our new revolving credit facility, we acquired of all of the issued and outstanding shares of capital stock of Concorde for a base purchase price of $50.0 million, less $1.3 million in net adjustments, for total cash consideration paid of $48.7 million. The final cash consideration paid is subject to closing working capital and other customary adjustments. See Note 4 of the notes to the condensed consolidated financial statements herein for additional details on the acquisition.

We believe that additional strategic uses of our cash resources may include consideration of additional strategic acquisitions and organic growth initiatives, purchase of real estate assets, subsidizing funding alternatives for our students, and the repurchase of common stock, among others. To the extent that potential acquisitions are large enough to require financing beyond cash from operations, cash and cash equivalents, and short-term investments, or we need capital to fund operations, new campus openings or expansion of programs at existing campuses, we may enter into additional credit facilities, issue debt or issue additional equity.

------

<u>[**Table of Contents**](#i3fd8c9cc921945018616af2cd8eacdac_7)</u> 

*Long-term Debt*

As of December 31, 2022, we had $163.5 million of long-term debt outstanding, which is comprised of two term loans and a revolving credit facility. Of the $163.5 million outstanding, $29.9 million relates to a term loan that bears interest at the rate of LIBOR plus 2.0% over the seven year term secured in connection with the Avondale, Arizona campus property purchased in December 2020. Approximately $38.0 million relates to a term loan that bears interest at the rate of SOFR plus 2.0% over the seven year term, secured in connection with the Lisle Campus property. The remaining $90.0 million relates to a revolving credit facility secured in connection with the Concorde acquisition. See Note 13 of the notes to the condensed consolidated financial statements herein for additional details on the term loans and the revolving credit facility.

*Dividends*

We currently do not pay a cash dividend on our common stock. For our outstanding Series A preferred shares, we currently pay preferred stock cash dividends of approximately $2.5 million during March and September of each fiscal year, which is subject to adjustment for any preferred stock conversions that occur during the year.

*Principal Sources of Liquidity*

Our principal source of liquidity is operating cash flows and existing cash and cash equivalents. A majority of our revenues are derived from Title IV Programs and various veterans' benefits programs. Federal regulations dictate the timing of disbursements of funds under Title IV Programs. Students must apply for new funding for each academic year consisting of 30-week periods. Loan funds are generally provided in two disbursements for each academic year. The first disbursement for first-time borrowers is usually received 30 days after the start of a student's academic year, and the second disbursement is typically received at the beginning of the 16th week from the start of the student's academic year. Under our UTI proprietary loan program, we bear all credit and collection risk and students are not required to begin repayment until six months after the student completes or withdraws from his or her program. Similarly, we bear all credit and collection risk for students paying through UTI cash payment plans and those under a retail installment contract at Concorde. These factors, together with the timing of when our students begin their programs, affect the timing and seasonality of our operating cash flow.

***Operating Activities***

Our net cash provided by operating activities was $2.8 million for the three months ended December 31, 2022, compared to $2.5 million for the three months ended December 31, 2021.

Net income, after adjustments for non-cash items, provided cash of $14.4 million. The non-cash items included $4.1 million for amortization of right-of-use assets for operating leases, $5.2 million for depreciation and amortization expense and $1.2 million for stock-based compensation expense and a change in deferred tax assets of $1.1 million.

Changes in operating assets and liabilities used cash of $11.6 million primarily due to the following:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• The decrease in accounts payable and accrued expenses used cash of $15.9 million primarily related to the timing of payments to vendors and for payroll and bonus accruals.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Changes in our operating lease liability, primarily as a result of rent payments, used cash of $5.0 million.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• The increase in deferred revenue provided cash of $4.6 million and was primarily attributable to the timing of student starts, the number of students in school and where they were at period end in relation to completion of their program at December 31, 2022 as compared to September 30, 2022.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• The decrease in receivables provided cash of $4.7 million and was primarily due to the timing of Title IV disbursements and other cash receipts on behalf of our students.

Net income, after adjustments for non-cash items, for the three months ended December 31, 2021 provided cash of $22.2 million. The non-cash items included $4.5 million for amortization of right-of-use assets for operating leases, $3.7 million for depreciation and amortization expense and $0.7 million for stock-based compensation expense.

Changes in operating assets and liabilities used cash of $19.8 million primarily due to the following:

------

<u>[**Table of Contents**](#i3fd8c9cc921945018616af2cd8eacdac_7)</u> 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• The decrease in accounts payable and accrued expenses used cash of $8.9 million primarily related to the timing of payments to vendors and for payroll and bonus accruals.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• The decrease in deferred revenue used cash of $8.7 million and was primarily attributable to the timing of student starts, the number of students in school and where they were at period end in relation to completion of their program at December 31, 2021 as compared to September 30, 2021.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• The change in other liabilities used cash of $3.0 million primarily due to the reclassification of the CARES payroll tax deferral to current liabilities.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Changes in our operating lease liability as a result of rent payments used cash of $2.6 million.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• The decrease in receivables provided cash of $4.9 million and was primarily due to the timing of Title IV disbursements and other cash receipts on behalf of our students.

***Investing Activities***

During the three months ended December 31, 2022, cash provided by investing activities was $5.2 million. The cash inflow was due to proceeds from maturities of held-to-maturity securities of $29.0 million, offset by cash outflow related to the purchase of Concorde for $17.0 million, net of cash consideration received. Additionally, we purchased property and equipment of $6.8 million which primarily related to capital expenditures for our new campuses in Austin, Texas and Miramar, Florida, and the rollout of new programs at our other campuses.

During the three months ended December 31, 2021, cash used in investing activities was $36.9 million. The cash outflow was primarily related to the purchase of MIAT for $26.1 million, net of cash consideration received. Additionally, we purchased property and equipment of $10.8 million which primarily related to capital expenditures for the Orlando, Florida and MMI, Phoenix consolidations, new campuses in Austin, Texas and Miramar, Florida, and other campus investments.

***Financing Activities***

During the three months ended December 31, 2022, cash provided by financing activities was $88.7 million which was primarily related to proceeds from our new revolving credit facility of $90.0 million, offset by $0.5 million in payments of payroll taxes on stock-based compensation through shares withheld, debt issuance costs related to the credit facility of $0.5 million and the repayment of long-term debt of $0.3 million.

During the three months ended December 31, 2021, cash provided by financing activities was $0.5 million which was primarily the payment of payroll taxes on stock-based compensation through shares withheld and payments on our term loan.

**Seasonality and Trends**

Our operating results normally fluctuate as a result of seasonal variations in our business, principally due to changes in total student population and costs associated with opening or expanding our campuses. Our student population varies as a result of new student enrollments, graduations and student attrition. Historically, UTI has had lower student populations in the third quarter than in the remainder of the year because fewer students are enrolled during the summer months. Additionally, UTI has had higher student populations in the fourth quarter than in the remainder of the year because more students enroll during this period. Concorde typically has higher student populations in January and August through October for its core programs and in February for its clinical programs. UTI and Concorde core program expenses do not vary significantly with changes in student population and revenues. Concorde clinical program expenses fluctuate based on the academic calendar and season due to the timing of clinical starts. We expect quarterly fluctuations in operating results to continue as a result of seasonal enrollment patterns. However, such patterns may change as a result of new school openings, new program introductions, increased enrollments of adult students or acquisitions.

**Critical Accounting Policies and Estimates**

The preparation of financial statements and related disclosures in conformity with GAAP and management's discussion and analysis of our financial condition and operating results require management to make judgments, assumptions and estimates that affect the amounts reported. There were no significant changes in our critical accounting policies and estimates in the three months ended December 31, 2022 from those previously disclosed in Part II, Item 7 of our <u>[202](http://www.sec.gov/ix?doc=/Archives/edgar/data/1261654/000126165422000105/uti-20220930.htm)[2](http://www.sec.gov/ix?doc=/Archives/edgar/data/1261654/000126165422000105/uti-20220930.htm)[Annual Report on Form 10-K](http://www.sec.gov/ix?doc=/Archives/edgar/data/1261654/000126165422000105/uti-20220930.htm)</u>.

------

<u>[**Table of Contents**](#i3fd8c9cc921945018616af2cd8eacdac_7)</u> 

**Recent Accounting Pronouncements**

For information regarding recent accounting pronouncements, see Note 3 of the notes to the condensed consolidated financial statements herein.

**Item 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK** 

Our principal exposure to market risk relates to changes in interest rates.

We invest our cash and cash equivalents in money market funds. As of December 31, 2022, we held $162.2 million in cash and cash equivalents. During the three months ended December 31, 2022, we earned interest income of $823 thousand. As we have a conservative investment policy, our financial exposure to fluctuations in interest rates related to our interest income is expected to remain low. We do not believe that the value or liquidity of our cash and cash equivalents and investments have been significantly impacted by current market events.

On May 12, 2021, we entered into a credit agreement to finance the Avondale property through a $31.2 million term loan that bears interest at the rate of LIBOR plus 2.0% with a maturity of seven years. As of December 31, 2022, the fair value of our long-term debt was $29.9 million and bears interest on the outstanding principal amount at a rate equal to the LIBOR plus 2.0%, which was 6.12% as of December 31, 2022.

On April 14, 2022, we entered into a credit agreement to finance the Lisle property through a $38.0 million term loan that bears interest at the rate of SOFR plus 2.0% with a maturity of seven years. As of December 31, 2022, the fair value of our long-term debt was $38.0 million and bears interest on the outstanding principal amount at a rate equal to the SOFR plus 2.0%, which was 6.12% as of December 31, 2022.

We believe the carrying value of the debt approximates fair value as the interest rate is a floating rate equal to the LIBOR or SOFR plus 2.0%, which is representative of market rates for similar instruments. It is anticipated that the fair market value of our debt will continue to be immaterially affected by fluctuations in interest rates and we do not believe that the value of our debt has been significantly impacted by current market events. The variable rate of interest on our long-term debt can expose us to interest rate volatility due to changes in LIBOR and SOFR. To mitigate this exposure, we entered into interest rate swap agreements that effectively fix the interest rates on 50% of the principal amounts of the term loans at 3.5% and 4.69% for the entire loan term on our Avondale debt and Lisle debt, respectively.

On November 18, 2022, we entered into a $100.0 million senior secured revolving credit facility that bears variable interest in a maturity of three years. On November 28, 2022, we drew $90.0 million from the credit facility in support of the closing of the Concorde acquisition at an interest rate of 6.54%.

During the three months ended December 31, 2022, we recorded interest expense of $1.4 million on our outstanding debt. Assuming all terms of our outstanding long-term debt remained the same, a hypothetical 10.0% change (up or down) in the LIBOR or SOFR rates would result in a $12.4 million change to our annual interest expense for the portion of the long-term debt not hedged by the interest rate swap agreement.

**Item 4. CONTROLS AND PROCEDURES**

**Disclosure Controls and Procedures**

Under the supervision and with the participation of our management, including our Chief Executive Officer and our Chief Financial Officer, we have evaluated the effectiveness of the design and operation of our disclosure controls and procedures (as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act), pursuant to Exchange Act Rule 13a-15 as of the end of the period covered by this report. Based upon that evaluation, the Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures as of December 31, 2022 were effective in ensuring that (i) information required to be disclosed by us in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the SEC's rules and forms and (ii) information required to be disclosed by us in the reports that we file or submit under the Exchange Act is accumulated and communicated to our management, including our principal executive and principal financial officers, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.

------

<u>[**Table of Contents**](#i3fd8c9cc921945018616af2cd8eacdac_7)</u> 

**Changes in Internal Control Over Financial Reporting** 

On December 1, 2022, we completed the acquisition of Concorde Career Colleges, Inc. We intend to exclude the acquired business from our assessment and report on internal control over financial reporting for the year ended September 30, 2023, as permitted under SEC rules. Other than the foregoing, there were no changes in our internal control over financial reporting identified in connection with the evaluation required by Exchange Act Rule 13a-15(d) or 15d-15(d) that occurred during the three months ended December 31, 2022 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

**Limitations on Effectiveness of Controls and Procedures**

Our management, including our Chief Executive Officer and our Chief Financial Officer, does not expect that our disclosure controls and procedures or our internal controls over financial reporting will prevent all error and all fraud. A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Further, the design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues, misstatements, errors and instances of fraud, if any, within our company have been or will be prevented or detected. These inherent limitations include the realities that judgments in decision-making can be faulty and that breakdowns can occur because of simple error or mistake. Controls also can be circumvented by the individual acts of some persons, by collusion of two or more people or by management override of the controls. The design of any system of controls is based in part on certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions. Projections of any evaluation of controls effectiveness to future periods are subject to risks that internal controls may become inadequate as a result of changes in conditions, or through the deterioration of the degree of compliance with policies or procedures.

------

<u>[**Table of Contents**](#i3fd8c9cc921945018616af2cd8eacdac_7)</u> 

**PART II. OTHER INFORMATION**

**Item 1. LEGAL PROCEEDINGS**

&nbsp;&nbsp;&nbsp;&nbsp;

In the ordinary conduct of our business, we are periodically subject to lawsuits, demands in arbitrations, investigations, regulatory proceedings or other claims, including, but not limited to, claims involving current and former students, routine employment matters, business disputes and regulatory demands. When we are aware of a claim or potential claim, we assess the likelihood of any loss or exposure. If it is probable that a loss will result and the amount of the loss can be reasonably estimated, we would accrue a liability for the loss. When a loss is not both probable and estimable, we do not accrue a liability. Where a loss is not probable but is reasonably possible, including if a loss in excess of an accrued liability is reasonably possible, we determine whether it is possible to provide an estimate of the amount of the loss or range of possible losses for the claim. Because we cannot predict with certainty the ultimate resolution of the legal proceedings (including lawsuits, investigations, regulatory proceedings or claims) asserted against us, it is not currently possible to provide such an estimate. The ultimate outcome of pending legal proceedings to which we are a party may have a material adverse effect on our business, cash flows, results of operations or financial condition.

**Item 1A. RISK FACTORS** 

In addition to the other information set forth in this Quarterly Report on Form 10-Q, including the information contained in Part I, Item 3, you should carefully consider the factors discussed in Part I, Item IA of our <u>[202](http://www.sec.gov/ix?doc=/Archives/edgar/data/1261654/000126165422000105/uti-20220930.htm)[2](http://www.sec.gov/ix?doc=/Archives/edgar/data/1261654/000126165422000105/uti-20220930.htm)[Annual Report on Form 10-K](http://www.sec.gov/ix?doc=/Archives/edgar/data/1261654/000126165422000105/uti-20220930.htm)</u>, which could materially affect our business, financial condition or operating results. The risks described in this Quarterly Report on Form 10-Q and in our <u>[202](http://www.sec.gov/ix?doc=/Archives/edgar/data/1261654/000126165422000105/uti-20220930.htm)[2](http://www.sec.gov/ix?doc=/Archives/edgar/data/1261654/000126165422000105/uti-20220930.htm)[Annual Report on Form 10-K](http://www.sec.gov/ix?doc=/Archives/edgar/data/1261654/000126165422000105/uti-20220930.htm)</u> are not the only risks we face. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may materially adversely affect our business, financial condition or operating results.

**Item 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS** 

None.

**Item 3. DEFAULTS UPON SENIOR SECURITIES**

None.

**Item 4. MINE SAFETY DISCLOSURES**

Not applicable.

**Item 5. OTHER INFORMATION**

None.

------

<u>[**Table of Contents**](#i3fd8c9cc921945018616af2cd8eacdac_7)</u> 

**Item 6. EXHIBITS**

The following exhibits required by Item 601 of Regulation S-K are filed or furnished with this report, as applicable:

---

| | |
|:---|:---|
| **Exhibit Number** | **Description** |
| 2.1 | <u>[Stock Purchase Agreement, dated May 3, 2022, by and among Universal Technical Institute, Inc., Concorde Career Colleges, Inc., Liberty Partners Holdings 28, L.L.C., Liberty Investment IIC, LLC, and Liberty Partners L.P. (incorporated by reference to Exhibit 10.1 to the Registrant's Current Report on Form 8-K dated May 3, 2022).](http://www.sec.gov/Archives/edgar/data/1261654/000119312522139032/d230789dex101.htm)</u> |
| 10.1 | <u>[Credit Agreement, dated as of November 18, 2022, by and among Universal Technical Institute, Inc., Fifth Third Bank, National Association, and the other loan parties thereto (incorporated by reference to Exhibit 10.1 to the Registrant's Current Report on Form 8-K dated November 21, 2022).](https://www.sec.gov/Archives/edgar/data/1261654/000119312522289578/d377692dex101.htm)</u> |
| 10.2 | <u>[Guaranty and Security Agreement, dated as of November 18, 2022, by and among Universal Technical Institute, Inc., Fifth Third Bank, National Association, and the other loan parties thereto (incorporated by reference to Exhibit 10.2 to the Registrant's Current Report on Form 8-K dated November 21, 2022).](https://www.sec.gov/Archives/edgar/data/1261654/000119312522289578/d377692dex102.htm)</u> |
| 31.1\* | <u>[Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.](exhibit311-q12023.htm)</u> |
| 31.2\* | <u>[Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.](exhibit312-q12023.htm)</u> |
| 32.1+ | <u>[Certification of Chief Executive Officer pursuant to 18 U.S.C. § 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.](exhibit321-q12023.htm)</u> |
| 32.2+ | <u>[Certification of Chief Financial Officer pursuant to 18 U.S.C. § 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.](exhibit322-q12023.htm)</u> |
| 101.INS\* | XBRL Instance Document. |
| 101.SCH\* | XBRL Taxonomy Extension Schema Document. |
| 101.CAL\* | XBRL Taxonomy Extension Calculation Linkbase Document. |
| 101.DEF\* | XBRL Taxonomy Extension Definition Linkbase Document. |
| 101.LAB\* | XBRL Taxonomy Extension Label Linkbase Document. |
| 101.PRE\* | XBRL Taxonomy Extension Presentation Linkbase Document. |
| 104 | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101) |

---

__________________

\* &nbsp;&nbsp;&nbsp;&nbsp;Filed herewith.

+ &nbsp;&nbsp;&nbsp;&nbsp;Furnished herewith.

------

<u>[**Table of Contents**](#i3fd8c9cc921945018616af2cd8eacdac_7)</u> 

**SIGNATURES** 

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

---

| | | | |
|:---|:---|:---|:---|
| | | UNIVERSAL TECHNICAL INSTITUTE, INC. | UNIVERSAL TECHNICAL INSTITUTE, INC. |
| Date: | February 9, 2023 | By: | */s/ Jerome A. Grant* |
|  |  | Name: | Jerome A. Grant |
|  |  | Title: | Chief Executive Officer (Principal Executive Officer) |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

## Exhibit 31.1

**Exhibit 31.1**

**Certification of Chief Executive Officer Pursuant to 18 U.S.C. Section 1350, As Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002**

I, Jerome A. Grant, certify that:

1. I have reviewed this Report on Form 10-Q of Universal Technical Institute, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;&nbsp;&nbsp;&nbsp;Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;&nbsp;&nbsp;&nbsp;Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;&nbsp;&nbsp;&nbsp;Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date: February 9, 2023

---

| |
|:---|
| */s/ Jerome A. Grant* |
| Jerome A. Grant |
| Chief Executive Officer |
| (Principal Executive Officer) |

---

## Exhibit 31.2

 **Exhibit 31.2**

**Certification of Chief Financial Officer Pursuant to 18 U.S.C. Section 1350, As Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002**

I, Troy R. Anderson, certify that:

1. I have reviewed this Report on Form 10-Q of Universal Technical Institute, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;&nbsp;&nbsp;&nbsp;Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;&nbsp;&nbsp;&nbsp;Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;&nbsp;&nbsp;&nbsp;Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date: February 9, 2023

---

| |
|:---|
| */s/ Troy R. Anderson* |
| Troy R. Anderson |
| Executive Vice President and Chief Financial Officer |
| (Principal Financial Officer and Principal Accounting Officer) |

---

## Exhibit 32.1

**Exhibit 32.1**

**Certification of CEO Pursuant to 18 U.S.C. Section 1350, As Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002**

In connection with the quarterly report of Universal Technical Institute, Inc. (the "Company") on Form 10-Q for the period ended December 31, 2022, as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Jerome A. Grant, Chief Executive Officer of the Company, certify, to the best of my knowledge, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1)&nbsp;&nbsp;&nbsp;&nbsp;The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2)&nbsp;&nbsp;&nbsp;&nbsp;The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

---

| | | |
|:---|:---|:---|
| Date: | February 9, 2023 | |
| | | */s/ Jerome A. Grant* |
| | | Jerome A. Grant |
| | | Chief Executive Officer |
| | | (Principal Executive Officer) |

---

This certification accompanies the Quarterly Report on Form 10-Q to which it relates, is not deemed filed with the Securities and Exchange Commission and is not to be incorporated by reference into any filing of Universal Technical Institute, Inc. under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended (whether made before or after the date of the Quarterly Report on Form 10-Q), irrespective of any general incorporation language contained in such filing.

&nbsp;&nbsp;&nbsp;&nbsp;

## Exhibit 32.2

**Exhibit 32.2**

**Certification of CFO Pursuant to 18 U.S.C. Section 1350, As Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002**

In connection with the quarterly report of Universal Technical Institute, Inc. (the "Company") on Form 10-Q for the period ended December 31, 2022, as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Troy R. Anderson, Chief Financial Officer of the Company, certify, to the best of my knowledge, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1)&nbsp;&nbsp;&nbsp;&nbsp;The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2)&nbsp;&nbsp;&nbsp;&nbsp;The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

---

| | | |
|:---|:---|:---|
| Date: | February 9, 2023 | |
| | | */s/ Troy R. Anderson* |
| | | Troy R. Anderson |
| | | Executive Vice President and Chief Financial Officer |
| | | (Principal Financial Officer and Principal Accounting Officer) |

---

This certification accompanies the Quarterly Report on Form 10-Q to which it relates, is not deemed filed with the Securities and Exchange Commission and is not to be incorporated by reference into any filing of Universal Technical Institute, Inc. under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended (whether made before or after the date of the Quarterly Report on Form 10-Q), irrespective of any general incorporation language contained in such filing.

<br>